https://curecurrent.com/trials/imaging-dopamine-d2-agonist-binding-sites-in-schizophrenia-123007https://curecurrent.com/trials/maternal-adversity-vulnerability-and-neurodevelopment-123008https://curecurrent.com/trials/estradiol-as-add-on-to-antipsychotics-123009https://curecurrent.com/trials/estradiol-patch-as-add-on-to-antipsychotics-in-patients-with-schizophrenia-schizoaffective-or-schizophreniform-disorder-123010https://curecurrent.com/trials/effect-evaluation-of-individual-placement-and-support-ips-123011https://curecurrent.com/trials/positron-emission-tomography-pet-study-investigating-dopamine-and-serotonin-receptor-occupancy-after-multiple-oral-dosin-123012https://curecurrent.com/trials/transcranial-direct-current-stimulation-and-effects-on-early-auditory-processing-in-schizophrenia-123013https://curecurrent.com/trials/using-short-message-service-as-a-means-of-clinical-engagement-in-early-psychosis-123014https://curecurrent.com/trials/a-study-to-determine-the-maximum-tolerated-dose-of-an-investigational-drug-in-subjects-with-schizophrenia-123015https://curecurrent.com/trials/target-engagement-of-the-early-auditory-processing-network-by-transcranial-direct-current-stimulation-tdcs-123016https://curecurrent.com/trials/brief-group-psychoeducation-for-schizophrenia-123017https://curecurrent.com/trials/clozapine-for-cannabis-use-in-schizophrenia-123018https://curecurrent.com/trials/the-clinical-and-socio-demographic-characteristics-of-young-people-aged-12-to-25-consulting-on-ambulatory-structures-in-123019https://curecurrent.com/trials/efficacy-and-tolerability-of-switching-to-ziprasidone-from-other-antipsychotics-123020https://curecurrent.com/trials/oral-status-of-patients-suffering-from-schizophrenia-followed-at-charles-perrens-hospital-123021https://curecurrent.com/trials/magnetic-stimulation-of-the-brain-in-schizophrenia-or-depression-123022https://curecurrent.com/trials/antipsychotic-effects-on-brain-function-in-schizophrenia-123023https://curecurrent.com/trials/cognitive-remediation-program-for-family-caregivers-in-schizophrenia-123024https://curecurrent.com/trials/adapted-cognitive-affective-remediation-for-cannabis-misuse-in-schizophrenia-123025https://curecurrent.com/trials/aripiprazole-abilify-maintena-collaborative-clinical-protocol-123026https://curecurrent.com/trials/evaluating-a-new-iloperidone-titration-scheme-in-bipolar-i-disorder-or-schizophrenia-123027https://curecurrent.com/trials/efficacy-of-metacognitive-training-for-schizophrenia-a-study-protocol-123028https://curecurrent.com/trials/survey-on-pre-ect-evaluation-and-ect-application-123029https://curecurrent.com/trials/alcohol-use-disorders-in-schizophrenia-123030https://curecurrent.com/trials/influence-of-vitamin-d-supplementation-on-serum-bdnf-level-and-cognitive-function-in-schizophrenia-123031https://curecurrent.com/trials/culturally-responsive-person-centered-care-for-psychosis-123032https://curecurrent.com/trials/glycine-vs-placebo-for-the-schizophrenia-prodrome-123033https://curecurrent.com/trials/transcranial-magnetic-stimulation-for-voices-123034https://curecurrent.com/trials/lurasidone-vs-olanzapine-on-neurotrophic-biomarkers-and-cardiometabolic-parameters-in-unmedicated-schizophrenia-123035https://curecurrent.com/trials/treatment-with-acamprosate-in-patients-with-schizophrenia-and-comorbid-alcoholism-123036https://curecurrent.com/trials/cognitive-training-and-enhanced-supported-employment-in-schizophrenia-123037https://curecurrent.com/trials/benefits-management-for-people-with-psychiatric-disabilities-123038https://curecurrent.com/trials/endocannabinoid-control-of-microglia-activation-as-a-new-therapeutic-target-in-the-treatment-of-schizophrenia-123039https://curecurrent.com/trials/the-effect-of-sertindole-and-risperidone-on-endophenotypic-markers-of-schizophrenia-123040https://curecurrent.com/trials/psychosocial-therapy-and-risperidone-treatment-in-work-performance-in-recent-onset-schizophrenia-123041https://curecurrent.com/trials/d-cycloserine-augmentation-of-cognitive-behavioral-therapy-for-delusions-123042https://curecurrent.com/trials/family-focused-therapy-for-youth-with-early-onset-bipolar-or-psychotic-disorders-123043https://curecurrent.com/trials/a-6-month-study-to-evaluate-sulforaphane-add-on-effects-in-treatment-of-schizophrenia-123044https://curecurrent.com/trials/tdcs-for-auditory-hallucinations-in-schizophrenia-123045https://curecurrent.com/trials/virtual-reality-training-for-social-skills-in-schizophrenia-123046https://curecurrent.com/trials/using-clinical-process-indicators-patient-reported-outcome-measures-proms-and-patient-reported-experience-measures-prems-123047https://curecurrent.com/trials/psychopathological-differences-between-asperger-syndrome-and-schizotypal-disorder-in-an-adult-sample-123048https://curecurrent.com/trials/efficacy-and-mechanisms-of-change-of-an-emotion-oriented-version-of-cognitive-behavioral-therapy-for-psychosis-123049https://curecurrent.com/trials/phenomics-and-genomics-of-clozapine-pharmacotherapy-123050https://curecurrent.com/trials/pilot-trial-of-emotion-focused-cognitive-behavior-therapy-for-patients-with-schizophrenia-123051https://curecurrent.com/trials/can-cognitive-training-decrease-reactive-aggression-123052https://curecurrent.com/trials/pact-for-individuals-with-serious-mental-illness-123053https://curecurrent.com/trials/adult-study-oxytocin-behavioral-123054https://curecurrent.com/trials/tracking-outcomes-in-psychosis-123055https://curecurrent.com/trials/psychoeducation-in-patients-who-diagnosed-with-schizophrenia-123056https://curecurrent.com/trials/texting-for-relapse-prevention-123057https://curecurrent.com/trials/the-evaluation-of-the-use-of-a-new-physical-health-plan-123058https://curecurrent.com/trials/the-effect-of-long-acting-antipsychotics-on-schizophrenia-patients-with-violence-risk-123059https://curecurrent.com/trials/cognitive-remediation-therapy-in-schizophrenia-effects-on-epigenetics-123060https://curecurrent.com/trials/deep-brain-stimulation-in-treatment-resistant-schizophrenia-123061https://curecurrent.com/trials/safety-and-tolerability-of-risperidone-implants-123062https://curecurrent.com/trials/expanded-game-squad-for-neurodiverse-youth-123063https://curecurrent.com/trials/study-in-stabilized-schizophrenic-patients-to-evaluate-the-pharmacokinetics-of-risperidone-and-9-hydroxy-oh-risperidone-123064https://curecurrent.com/trials/the-street-smart-group-a-feasibility-trial-of-a-group-intervention-targeting-anxiety-processes-in-paranoia-123065https://curecurrent.com/trials/efficacy-of-transcranial-direct-current-stimulation-in-treatment-of-cognitive-deficits-in-early-stages-of-psychosis-123066https://curecurrent.com/trials/perception-processing-in-schizophrenia-patients-and-normal-population-123067https://curecurrent.com/trials/neurophysiological-evaluation-of-schizophrenia-patients-after-cognitive-and-physical-intervention-123068https://curecurrent.com/trials/study-of-the-activation-of-proinflammatory-pathways-of-toll-like-receptors-in-schizophrenia-patients-123069https://curecurrent.com/trials/prepulse-inhibition-ppi-of-startle-reflex-in-schizophrenia-patients-related-to-type-of-treatment-and-illness-duration-123070https://curecurrent.com/trials/effectiveness-of-second-generation-antipsychotics-in-first-episode-psychosis-patients-1-year-follow-up-123071https://curecurrent.com/trials/assessment-of-the-effectiveness-of-the-nect-program-123072https://curecurrent.com/trials/modulating-human-cortical-plasticity-with-transcranial-electrical-stimulation-123073https://curecurrent.com/trials/a-study-of-alks-3831-in-adults-with-schizophrenia-the-enlighten-2-study-123074https://curecurrent.com/trials/dopamine-d2-and-d3-receptor-occupancy-and-clinical-response-in-older-patients-with-schizophrenia-123075https://curecurrent.com/trials/hope-team-clinical-high-risk-group-cbsst-123076https://curecurrent.com/trials/evaluating-a-novel-mobile-app-for-social-cognition-in-psychosis-123077https://curecurrent.com/trials/prospective-studies-of-the-pathogenesis-of-schizophrenia-123078https://curecurrent.com/trials/a-study-of-lurasidone-hcl-in-subjects-with-schizophrenia-123079https://curecurrent.com/trials/the-relevance-between-the-microrna-30e-in-plasma-and-the-prognosis-of-schizophrenia-patients-123080https://curecurrent.com/trials/phase-2-trial-of-a-nicotinic-agonist-in-schizophrenia-123081https://curecurrent.com/trials/clinical-and-genetic-influencing-factors-on-clozapine-pharmacokinetics-123082https://curecurrent.com/trials/action-based-cognitive-remediation-for-first-episode-psychosis-123083https://curecurrent.com/trials/effect-of-metacognitive-therapy-on-negative-symptoms-a-case-series-123084https://curecurrent.com/trials/multi-dimensional-investigations-of-negative-emotions-and-drug-resistant-auditory-verbal-hallucinations-in-psychosis-123085https://curecurrent.com/trials/enhancing-motivation-in-recent-onset-schizophrenia-123086https://curecurrent.com/trials/efficacy-of-lu-af35700-in-patients-with-early-in-disease-or-late-in-disease-treatment-resistant-schizophrenia-123087https://curecurrent.com/trials/novel-candidate-genes-for-treatment-response-to-antipsychotics-in-schizophrenia-123088https://curecurrent.com/trials/neurocognitive-effectiveness-in-treatment-of-first-episode-non-affective-psychosis-3-years-follow-up-123089https://curecurrent.com/trials/cost-effectiveness-of-interventions-in-first-episode-psychosis-123090https://curecurrent.com/trials/10-year-follow-up-of-clinical-outcome-after-antipsychotic-treatment-discontinuation-in-psychosis-individuals-123091https://curecurrent.com/trials/effects-of-transcranial-direct-current-stimulation-tdcs-on-persistent-auditory-verbal-hallucinations-in-schizophrenia-123092https://curecurrent.com/trials/efficacy-of-social-cognitive-training-sct-in-recent-onset-psychosis-123093https://curecurrent.com/trials/symptom-based-treatment-affects-brain-plasticity-the-role-of-verbal-auditory-hallucinations-123094https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-efficacy-of-pf-04958242-in-subjects-with-cognitive-impairment-associated-with-schizop-123095https://curecurrent.com/trials/selective-estrogen-receptor-modulators-for-women-of-child-bearing-age-with-schizophrenia-123096https://curecurrent.com/trials/study-to-evaluate-the-safety-tolerability-and-pharmacokinetics-of-single-doses-of-pf-04958242-in-healthy-volunteers-123097https://curecurrent.com/trials/an-open-label-multicenter-rollover-long-term-study-of-aripiprazole-intramuscular-depot-in-participants-with-schizophreni-123098https://curecurrent.com/trials/a-long-term-trial-of-opc-34712-in-patients-with-schizophrenia-123099https://curecurrent.com/trials/shared-decision-making-in-psychiatric-inpatient-care-123100https://curecurrent.com/trials/pediatric-open-label-extension-study-123101https://curecurrent.com/trials/vitamin-b6-and-b12-in-the-treatment-of-movement-disorders-induced-by-antipsychotics-123102https://curecurrent.com/trials/mindfulness-based-illness-management-program-for-schizophrenia-123103https://curecurrent.com/trials/decifer-depression-and-citalopram-in-first-episode-recovery-123104https://curecurrent.com/trials/electrophysiology-and-blood-flow-in-patients-with-schizophrenia-and-their-siblings-123105https://curecurrent.com/trials/magnetic-resonance-imaging-mri-of-neuropsychiatric-patients-and-healthy-volunteers-123106https://curecurrent.com/trials/influence-of-nicotine-on-cognitive-function-in-schizophrenic-patients-with-and-without-comorbid-drug-dependence-123107https://curecurrent.com/trials/transcranial-direct-current-brain-stimulation-to-treat-patients-with-childhood-onset-schizophrenia-123108https://curecurrent.com/trials/assessment-of-craving-in-nicotine-dependent-patients-with-schizophrenia-using-virtual-reality-123109https://curecurrent.com/trials/symptom-based-treatment-affects-brain-plasticity-cognitive-training-in-patients-with-affective-symptoms-123110https://curecurrent.com/trials/treatment-of-refractory-schizophrenia-with-riluzole-123111https://curecurrent.com/trials/dopamine-function-and-reward-processing-in-schizophrenia-123112https://curecurrent.com/trials/effects-of-modafinil-on-brain-function-in-patients-with-schizophrenia-123113https://curecurrent.com/trials/brain-tissue-collection-for-neuropathological-studies-123114https://curecurrent.com/trials/open-label-study-of-the-efficacy-of-intranasal-oxytocin-in-schizophrenia-123115https://curecurrent.com/trials/a-concierge-model-of-cae-plus-lai-in-individuals-with-schizophrenia-at-risk-for-treatment-non-adherence-and-homelessness-123116https://curecurrent.com/trials/effect-of-intranasal-vasopressin-on-cooperative-behavior-in-schizophrenia-123117https://curecurrent.com/trials/vr-therapy-for-psychosis-negative-symptoms-v-nest-123118https://curecurrent.com/trials/efficacy-of-equine-assisted-therapy-on-negative-symptoms-in-patients-with-schizophrenia-123119https://curecurrent.com/trials/improving-cognition-in-schizophrenia-using-non-invasive-brain-stimulation-123120https://curecurrent.com/trials/perinatal-mental-health-care-in-switzerland-123121https://curecurrent.com/trials/theta-burst-stimulation-for-schizophrenia-123122https://curecurrent.com/trials/effect-of-lu-af35700-in-patients-with-treatment-resistant-schizophrenia-123123https://curecurrent.com/trials/metyrosine-demser-for-the-treatment-of-psychotic-disorders-in-patients-with-velocardiofacial-syndrome-123124https://curecurrent.com/trials/repetitive-transcranial-magnetic-stimulation-rtms-self-referential-processing-rtms-srp-123125https://curecurrent.com/trials/study-of-the-pf-04958242-blood-concentrations-of-a-capsule-formulation-of-pf-04958242-compared-to-a-solution-formulation-123126https://curecurrent.com/trials/a-study-to-examine-the-effects-of-pf-04958242-on-ketamine-induced-cognitive-impairment-in-healthy-volunteers-123127https://curecurrent.com/trials/study-to-evaluate-the-safety-tolerability-and-pharmacokinetics-of-repeated-doses-of-pf-04958242-in-healthy-volunteers-123128https://curecurrent.com/trials/a-study-to-examine-the-safety-tolerability-and-pharmacokinetics-of-pf-04958242-in-psychiatrically-stable-subjects-with-s-123129https://curecurrent.com/trials/the-family-voice-study-123130https://curecurrent.com/trials/antipsychotic-effects-of-oxytocin-123131https://curecurrent.com/trials/a-clinical-trial-of-lurasidone-in-treatment-of-schizophrenia-123132https://curecurrent.com/trials/neurobiological-effects-of-oxytocin-in-schizophrenia-imaging-study-123133https://curecurrent.com/trials/a-study-of-staccato-loxapine-adasuve-for-inhalation-123134https://curecurrent.com/trials/reducing-cardiovascular-risk-in-adults-with-serious-mental-illness-123135https://curecurrent.com/trials/clinical-trial-of-dipyridamole-in-schizophrenia-123136https://curecurrent.com/trials/application-of-a-mindfulness-and-self-compassion-program-in-patients-with-schizophrenia-randomized-controlled-trial-123137https://curecurrent.com/trials/knowledge-and-perception-of-smoking-risks-consequences-123138https://curecurrent.com/trials/efficiency-of-the-french-translation-social-cognition-and-interactive-training-scit-program-123139https://curecurrent.com/trials/aerobic-exercise-for-cognition-in-schizophrenia-123140https://curecurrent.com/trials/efficiency-of-art-therapy-in-psychotic-disorders-123141https://curecurrent.com/trials/anatomical-and-structural-connectivity-in-two-psychotic-phenotypes-periodic-catatonia-and-cataphasia-123142https://curecurrent.com/trials/art-therapy-in-acute-psychiatry-123143https://curecurrent.com/trials/long-term-exercise-training-therapy-versus-usual-care-in-patients-with-schizophrenia-123144https://curecurrent.com/trials/a-dose-finding-trial-of-opc-34712-in-patients-with-schizophrenia-123145https://curecurrent.com/trials/oxytocin-and-social-cognition-in-schizophrenia-123146https://curecurrent.com/trials/quantitative-investigation-of-environment-and-participation-123147https://curecurrent.com/trials/metacognitive-training-and-insight-in-schizophrenia-123148https://curecurrent.com/trials/risperidone-treatment-in-schizophrenia-patients-who-are-currently-taking-clozapine-123149https://curecurrent.com/trials/double-blind-placebo-controlled-study-of-adjunctive-aripiprazole-for-symptomatic-hyperprolactinemia-in-premenopausal-wom-123150https://curecurrent.com/trials/neuroendocrine-and-immune-response-to-stress-in-schizophrenia-123151https://curecurrent.com/trials/gluten-free-diet-in-people-with-schizophrenia-a-pilot-study-123152https://curecurrent.com/trials/randomized-controlled-trial-of-a-gluten-free-diet-in-patients-with-schizophrenia-who-are-gliadin-positive-123153https://curecurrent.com/trials/multimodal-physical-therapy-program-in-schizophrenia-123154https://curecurrent.com/trials/homeless-youth-study-stepping-stone-2-0-123155https://curecurrent.com/trials/intracellular-tight-junction-permeability-in-schizophrenia-focus-on-zonulin-123156https://curecurrent.com/trials/treatment-of-social-cognition-in-schizophrenia-trial-123157https://curecurrent.com/trials/tobacco-craving-and-triggers-in-persons-with-schizophrenia-123158https://curecurrent.com/trials/biomarker-study-of-acamprosate-in-schizophrenia-123159https://curecurrent.com/trials/oxytocin-add-on-study-for-stable-schizophrenic-patients-123160https://curecurrent.com/trials/18-fluorine-f-dopa-determinants-and-predictors-of-treatment-response-in-psychosis-123161https://curecurrent.com/trials/rasagiline-in-the-treatment-of-persistent-negative-symptoms-of-schizophrenia-123162https://curecurrent.com/trials/oxytocin-and-cbsst-for-people-with-schizophrenia-123163https://curecurrent.com/trials/therapeutic-drug-monitoring-for-individualized-clozapine-therapy-123164https://curecurrent.com/trials/predicting-antipsychotic-discontinuation-in-psychosis-123165https://curecurrent.com/trials/benefits-of-physical-exercise-in-schizophrenia-123166https://curecurrent.com/trials/effects-of-hyperprolactinemia-induced-by-antipsychotic-drugs-on-bone-metabolism-123167https://curecurrent.com/trials/psychosis-and-affective-research-domains-and-intermediate-phenotypes-123168https://curecurrent.com/trials/the-imaging-genetic-study-of-schizophrenia-and-family-123169https://curecurrent.com/trials/community-based-cognitive-training-in-early-schizophrenia-123170https://curecurrent.com/trials/role-of-antioxidants-vitamin-c-and-e-in-the-management-of-schizophrenia-123171https://curecurrent.com/trials/effects-of-neurocognitive-and-social-cognitive-remediation-in-patients-at-ultra-high-risk-of-psychosis-123172https://curecurrent.com/trials/nicotinic-enhancement-of-cognitive-remediation-training-in-schizophrenia-123173https://curecurrent.com/trials/study-investigating-the-effect-of-lu-af35700-on-cardiac-repolarization-in-men-and-women-with-schizophrenia-and-schizoaff-123174https://curecurrent.com/trials/evaluation-the-impact-of-self-stigma-reduction-program-on-psychosocial-outcomes-among-people-diagnosed-with-schizophreni-123175https://curecurrent.com/trials/patient-s-preference-between-conventional-oral-olanzapine-tablet-vs-olanzapine-orodispersible-tablet-123176https://curecurrent.com/trials/virtual-rehabilitation-for-the-treatment-of-motivational-deficits-in-schizophrenia-123177https://curecurrent.com/trials/effects-of-oxytocin-nasal-spray-on-social-affiliation-123178https://curecurrent.com/trials/adjunctive-selective-estrogen-receptor-modulators-on-negative-and-cognitive-symptoms-of-schizophrenia-in-women-123179https://curecurrent.com/trials/have-a-good-grasp-of-the-worldthe-world-123180https://curecurrent.com/trials/oxytocin-as-adjunctive-treatment-of-schizophrenia-123181https://curecurrent.com/trials/the-treatment-efficacy-of-combination-atypical-antipsychotics-with-sertraline-in-patients-with-schizophrenia-123182https://curecurrent.com/trials/anti-inflammatories-and-adolescent-schizophrenia-123183https://curecurrent.com/trials/a-research-in-pharmacogenomics-and-accurate-medication-of-risperidone-123184https://curecurrent.com/trials/antipsychotics-and-blood-vessel-function-123185https://curecurrent.com/trials/medactive-a-smartphone-intervention-to-improve-adherence-to-antipsychotic-medications-123186https://curecurrent.com/trials/adjunctive-minocycline-in-clozapine-treated-schizophrenia-patients-123187https://curecurrent.com/trials/effects-of-intranasal-oxytocin-on-satiety-signaling-in-people-with-schizophrenia-123188https://curecurrent.com/trials/exploring-the-effect-of-baduanjin-on-the-metabolic-parameters-and-body-mass-index-of-people-with-schizophrenia-123189https://curecurrent.com/trials/a-study-of-cariprazine-in-patients-with-chronic-stable-schizophrenia-123190https://curecurrent.com/trials/adjunctive-treatment-for-decreasing-symptoms-of-schizophrenia-123191https://curecurrent.com/trials/screening-protocol-for-research-participants-123192https://curecurrent.com/trials/new-antipsychotic-strategies-quetiapine-and-risperidone-vs-fluphenazine-in-treatment-resistant-schizophrenia-123193https://curecurrent.com/trials/effects-of-smoking-cues-on-tobacco-craving-responses-and-the-reinforcing-efficacy-of-cigarettes-in-smokers-with-and-with-123194https://curecurrent.com/trials/atomoxetine-as-an-adjunct-to-novel-antipsychotic-medication-in-the-treatment-of-cognitive-deficits-of-schizophrenia-123195https://curecurrent.com/trials/brain-blood-flow-changes-elicited-by-oxytocin-in-volunteers-with-and-without-schizophrenia-123196https://curecurrent.com/trials/schizophrenia-and-the-gut-microbiome-123197https://curecurrent.com/trials/music-to-reduce-use-of-smoking-in-patients-with-schizophrenia-123198https://curecurrent.com/trials/evaluating-two-types-of-cognitive-training-in-veterans-with-schizophrenia-123199https://curecurrent.com/trials/the-role-of-nitric-oxide-in-cognition-in-schizophrenia-123200https://curecurrent.com/trials/a-study-to-determine-pharmacokinetic-characteristics-of-ly03010-versus-invega-sustenna-in-schizophrenia-patients-123201https://curecurrent.com/trials/real-time-mobile-cognitive-behavioral-intervention-for-serious-mental-illness-123202https://curecurrent.com/trials/measuring-beliefs-and-norms-about-persons-with-mental-illness-123203https://curecurrent.com/trials/validating-and-optimizing-model-of-antipsychotics-selection-123204https://curecurrent.com/trials/sensorimotor-gating-in-schizophrenia-123205https://curecurrent.com/trials/anticonvulsant-mood-stabilizers-antipsychotic-drugs-and-the-insulin-resistance-syndrome-123206https://curecurrent.com/trials/role-of-anti-inflammatory-agents-in-patients-with-schizophrenia-123207https://curecurrent.com/trials/minocycline-and-or-omega-3-fatty-acids-added-to-treatment-as-usual-for-at-risk-mental-states-123208https://curecurrent.com/trials/the-effect-of-a-community-based-lat-treated-management-model-on-the-violence-risk-of-patients-with-schizophrenia-123209https://curecurrent.com/trials/compensatory-cognitive-training-for-schizophrenia-123210https://curecurrent.com/trials/add-on-hd-hf-trns-over-bilateral-dlpfc-for-treating-patients-with-schizophrenia-123211https://curecurrent.com/trials/method-of-level-mol-therapy-for-psychosis-123212https://curecurrent.com/trials/brain-image-markers-associated-with-cognitive-training-and-aerobic-exercise-in-schizophrenia-123213https://curecurrent.com/trials/nicotine-receptor-density-response-to-nicotine-patch-pt-2-extended-treatment-123214https://curecurrent.com/trials/study-on-communication-comprehension-in-the-schizophrenic-spectrum-123215https://curecurrent.com/trials/long-term-study-of-cariprazine-in-patients-with-schizophrenia-123216https://curecurrent.com/trials/a-long-term-safety-and-tolerability-study-of-alks-3831-in-adults-with-schizophrenia-123217https://curecurrent.com/trials/creating-live-interactions-to-mitigate-barriers-123218https://curecurrent.com/trials/first-episode-schizophrenia-and-cannabis-related-disorder-study-123219https://curecurrent.com/trials/feasibility-and-preliminary-effect-of-baduanjin-program-for-people-diagnosed-with-schizophrenia-123220https://curecurrent.com/trials/a-clinical-study-to-evaluate-the-bioavailability-between-two-products-containing-paliperidone-100-mg-in-the-form-of-a-pr-123221https://curecurrent.com/trials/the-impact-of-dietary-habits-and-nutrition-intervention-on-metabolic-syndrome-in-individuals-with-schizophrenia-123222https://curecurrent.com/trials/rtms-for-working-memory-deficits-in-schizophrenia-123223https://curecurrent.com/trials/effectiveness-of-second-generation-antipsychotics-in-first-episode-psychosis-patients-3-year-follow-up-123224https://curecurrent.com/trials/mobile-health-technology-to-enhance-abstinence-in-smokers-with-schizophrenia-123225https://curecurrent.com/trials/music-therapy-towards-schizophrenia-negative-symptoms-123226https://curecurrent.com/trials/the-efficacy-and-safety-of-a-selective-estrogen-receptor-beta-agonist-ly500307-for-negative-symptoms-and-cognitive-impai-123227https://curecurrent.com/trials/memantine-for-the-prevention-of-cognitive-dysfunction-and-negative-symptoms-in-patients-with-acute-schizophrenia-123228https://curecurrent.com/trials/memantine-for-the-treatment-of-cognitive-dysfunction-and-negative-symptoms-in-patients-with-chronic-schizophrenia-123229https://curecurrent.com/trials/research-of-anatomo-functional-biomarkers-in-schizophrenia-123230https://curecurrent.com/trials/prednisolone-addition-for-patients-with-recent-onset-psychotic-disorder-123231https://curecurrent.com/trials/examining-risk-factors-for-atypical-antipsychotic-metabolic-side-effects-123232https://curecurrent.com/trials/a-new-paradigm-for-illness-monitoring-and-relapse-prevention-in-schizophrenia-123233https://curecurrent.com/trials/a-randomised-controlled-trial-of-coenzyme-q10-in-patients-with-schizophrenia-and-schizoaffective-disorder-123234https://curecurrent.com/trials/safety-and-efficacy-of-cariprazine-rgh-188-in-the-acute-exacerbation-of-schizophrenia-123235https://curecurrent.com/trials/study-on-predictiors-and-mechanism-of-conversion-to-psychosis-in-individuals-at-ultra-high-risk-group-123236https://curecurrent.com/trials/comparison-of-ketamine-combine-propofol-vs-propofol-anesthesia-in-schizophrenia-electroconvulsive-therapy-123237https://curecurrent.com/trials/a-multi-modal-approach-to-addressing-cardiovascular-risk-and-building-resilience-in-youths-with-psychosis-123238https://curecurrent.com/trials/dyad-oxytocin-study-dos-123239https://curecurrent.com/trials/piloting-mol-intervention-for-neuroleptic-decision-making-123240https://curecurrent.com/trials/adult-study-oxytocin-fmri-123241https://curecurrent.com/trials/effectiveness-of-a-problem-solving-intervention-for-common-adolescent-mental-health-problems-in-india-123242https://curecurrent.com/trials/oxytocin-meg-study-123243https://curecurrent.com/trials/adult-oxytocin-study-123244https://curecurrent.com/trials/effects-of-risperdal-consta-on-ability-to-benefit-from-social-skills-training-in-schizophrenia-123245https://curecurrent.com/trials/curcumin-as-a-novel-treatment-to-improve-cognitive-dysfunction-in-schizophrenia-123246https://curecurrent.com/trials/schizophrenia-treatment-with-electric-transcranial-stimulation-123247https://curecurrent.com/trials/development-of-a-mobile-system-for-self-management-of-schizophrenia-sos-123248https://curecurrent.com/trials/risperidone-long-acting-versus-oral-risperidone-in-patients-with-schizophrenia-and-alcohol-use-disorder-123249https://curecurrent.com/trials/evaluation-of-internet-based-cognitive-behavioral-self-help-treatments-for-people-with-psychosis-123250https://curecurrent.com/trials/the-effect-of-n-acetyl-cysteine-on-cortical-erosion-in-early-stage-schizophrenia-123251https://curecurrent.com/trials/adaptation-of-cognitive-enhancement-therapy-for-persons-at-clinical-high-risk-for-psychosis-123252https://curecurrent.com/trials/nicotinic-receptors-and-schizophrenia-123253https://curecurrent.com/trials/the-mid-term-effect-of-repeated-transcranial-magnetic-stimulation-on-schizophrenia-123254https://curecurrent.com/trials/study-of-add-on-ramelteon-therapy-on-sleep-and-circadian-rhythm-disruption-in-patients-with-schizophrenia-123255https://curecurrent.com/trials/high-frequency-rtms-treatment-for-cognitive-impairments-in-chronic-schizophrenia-patients-123256https://curecurrent.com/trials/transcranial-magnetic-stimulation-to-improve-gesture-control-123257https://curecurrent.com/trials/alleviating-the-metabolic-side-effects-of-antipsychotic-medications-123258https://curecurrent.com/trials/study-to-demonstrate-cognitive-enhancing-effects-of-bf2-649-123259https://curecurrent.com/trials/neurostimulation-enhanced-behavioral-remediation-of-social-cognition-in-schizophrenia-123260https://curecurrent.com/trials/cognate-patient-care-insight-scale-123261https://curecurrent.com/trials/impact-of-case-management-on-therapeutic-alliance-with-first-episode-psychosis-patients-camat-123262https://curecurrent.com/trials/rtms-treatment-for-positive-and-negative-symptoms-of-schizophrenia-123263https://curecurrent.com/trials/the-benefit-of-minocycline-on-negative-symptoms-in-schizophrenia-extent-and-mechanisms-123264https://curecurrent.com/trials/the-effects-of-prebiotics-on-cognitive-functioning-and-weight-gain-in-psychosis-123265https://curecurrent.com/trials/fingolimod-in-schizophrenia-patients-123266https://curecurrent.com/trials/ketamine-s-effect-changes-the-cortical-electrophysiological-activity-related-to-semantic-affective-dimension-of-pain-123267https://curecurrent.com/trials/comparison-of-antipsychotic-combination-treatment-of-olanzapine-and-amisulpride-to-monotherapy-123268https://curecurrent.com/trials/aripiprazole-once-monthly-versus-daily-oral-atypical-antipsychotic-treatment-in-patients-with-recent-onset-schizophrenia-123269https://curecurrent.com/trials/aripiprazole-abilify-maintena-collaborative-clinical-protocol-123270https://curecurrent.com/trials/paliperidone-er-invega-on-depressive-symptoms-of-schizophrenia-patients-123271https://curecurrent.com/trials/a-twelve-week-open-label-extension-study-in-patients-with-schizophrenia-123272https://curecurrent.com/trials/study-on-abnormal-dopamine-synthesis-and-connectivity-according-to-the-antipsychotic-treatment-response-in-schizophrenia-123273https://curecurrent.com/trials/validation-of-receptor-occupancy-simulation-123274https://curecurrent.com/trials/stem-cell-research-on-subjects-at-genetic-high-risk-for-schizophrenia-123275https://curecurrent.com/trials/pharmacokinetic-study-of-lurasidone-after-multiple-oral-administration-in-healthy-human-subjects-123276https://curecurrent.com/trials/optimizing-cognitive-remediation-outcomes-in-schizophrenia-123277https://curecurrent.com/trials/cognitive-remediation-of-schizophrenia-in-a-community-mental-health-setting-123278https://curecurrent.com/trials/novel-smoking-cessation-drug-for-schizophrenia-123279https://curecurrent.com/trials/pentosan-polysulfate-sodium-and-meclofenamic-acid-as-treatments-in-patients-with-psychotic-disorders-123280https://curecurrent.com/trials/positive-emotions-program-for-schizophrenia-peps-123281https://curecurrent.com/trials/smoking-cessation-with-varenicline-in-schizophrenia-antipsychotic-induced-neurological-symptoms-as-correlates-123282https://curecurrent.com/trials/compassion-focused-therapy-for-distressing-experiences-123283https://curecurrent.com/trials/effectiveness-of-the-remedrugby-program-123284https://curecurrent.com/trials/treatment-of-schizophrenia-and-comorbid-cannabis-use-disorder-comparing-clozapine-to-treatment-as-usual-123285https://curecurrent.com/trials/the-optimal-treatment-for-treatment-resistant-schizophrenia-123286https://curecurrent.com/trials/cross-sectional-iloperidone-ivgtt-123287https://curecurrent.com/trials/an-evaluation-of-a-psychoeducation-program-in-individuals-diagnosed-with-schizophrenia-123288https://curecurrent.com/trials/effects-of-aripiprazole-lai-on-phychosocial-cognitive-functioning-pt-reported-acceptabilityoftreatment-in-sch-123289https://curecurrent.com/trials/effects-of-pentazocine-versus-lorazepam-on-manic-symptoms-123290https://curecurrent.com/trials/rct-examining-the-effectiveness-of-digital-picture-frame-use-in-inpatient-setting-123291https://curecurrent.com/trials/comparison-of-propofol-target-controlled-infusion-anesthesia-and-bolus-injection-in-electroconvulsive-therapy-123292https://curecurrent.com/trials/cognitive-remediation-and-sheltered-employment-in-schizophrenia-123293https://curecurrent.com/trials/the-potential-efficacy-of-the-chinese-health-improvement-profile-a-pilot-clustered-randomised-controlled-trial-123294https://curecurrent.com/trials/mindfulness-based-social-cognition-training-for-psychosis-socialmind-a-feasibility-study-123295https://curecurrent.com/trials/safety-and-efficacy-of-pyridoxal-5-phosphate-in-the-treatment-of-tardive-dyskinesia-123296https://curecurrent.com/trials/early-predictors-of-poor-treatment-response-in-patients-with-schizophrenia-treated-with-atypical-antipsychotics-123297https://curecurrent.com/trials/monitoring-and-management-for-metabolic-side-effects-of-antipsychotics-123298https://curecurrent.com/trials/double-blind-trial-of-a-probiotic-supplement-to-reduce-the-symptoms-of-schizophrenia-123299https://curecurrent.com/trials/a-study-to-examine-safety-pharmacokinetics-and-pharmacodynamic-of-pf-06412562-in-subjects-with-schizophrenia-123300https://curecurrent.com/trials/waist-circumference-measurements-in-schizophrenic-patients-123301https://curecurrent.com/trials/target-engagement-for-oxytocin-dose-ranging-study-123302https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-alks-9072-also-known-as-aripiprazole-lauroxil-alks-9070-or-aristada-in-su-123303https://curecurrent.com/trials/a-double-blind-trial-of-adjunctive-valacyclovir-to-improve-cognition-in-early-phase-schizophrenia-123304https://curecurrent.com/trials/the-role-of-personal-identity-in-psychotic-symptoms-a-study-with-the-repertory-grid-technique-123305https://curecurrent.com/trials/efficacy-and-tolerability-study-of-betahistine-to-ameliorate-antipsychotic-associated-weight-gain-123306https://curecurrent.com/trials/family-intervention-in-recent-onset-schizophrenia-treatment-first-123307https://curecurrent.com/trials/clinical-trial-of-avl-3288-in-schizophrenia-patients-123308https://curecurrent.com/trials/glutamate-brain-connectivity-and-duration-of-untreated-psychosis-123309https://curecurrent.com/trials/transcranial-direct-current-stimulation-tdcs-as-a-treatment-for-cognitive-deficits-in-schizophrenic-123310https://curecurrent.com/trials/sodium-butyrate-for-improving-cognitive-function-in-schizophrenia-123311https://curecurrent.com/trials/examining-persistence-in-smokers-with-schizophrenia-123312https://curecurrent.com/trials/neurophysiological-studies-in-schizophrenia-and-psychiatric-disorders-123313https://curecurrent.com/trials/curcumin-addition-to-antipsychotic-treatment-in-chronic-schizophrenia-patients-123314https://curecurrent.com/trials/clinical-evaluation-of-acupuncture-treatment-for-negative-symptoms-of-schizophrenia-123315https://curecurrent.com/trials/role-of-an-e-cigarette-on-smoking-displacement-in-smokers-with-schizophrenia-123316https://curecurrent.com/trials/a-pharmacokinetic-study-of-lurasidone-after-single-oral-administration-in-healthy-subjects-123317https://curecurrent.com/trials/exercise-and-overnight-motor-sequence-task-123318https://curecurrent.com/trials/treatment-of-alcohol-dependence-and-comorbid-bipolar-disorder-123319https://curecurrent.com/trials/effectiveness-of-neuroadaptive-cognitive-training-in-adolescents-at-risk-for-psychosis-123320https://curecurrent.com/trials/probiotics-to-prevent-relapse-after-hospitalization-for-mania-123321https://curecurrent.com/trials/impact-of-video-presentations-on-medical-students-attitudes-toward-mental-illness-123322https://curecurrent.com/trials/tocilizumab-as-add-on-treatment-for-residual-positive-negative-and-cognitive-symptoms-of-schizophrenia-123323https://curecurrent.com/trials/emotional-response-in-psychiatric-and-control-participants-123324https://curecurrent.com/trials/electronic-decision-support-systems-for-smokers-with-severe-mental-illness-123325https://curecurrent.com/trials/evaluating-isradipine-for-cognitive-enhancement-in-schizophrenia-and-schizoaffective-disorder-123326https://curecurrent.com/trials/cognitive-behavioral-therapy-for-the-prevention-of-paranoia-in-adolescents-at-high-risk-123327https://curecurrent.com/trials/transcranial-magnetic-stimulation-tms-for-patients-with-treatment-resistant-auditory-verbal-hallucination-123328https://curecurrent.com/trials/a-study-of-aripiprazole-lauroxil-also-known-as-aristada-tm-in-subjects-with-schizophrenia-123329https://curecurrent.com/trials/cognitive-behavioral-therapy-for-paranoia-in-schizophrenia-123330https://curecurrent.com/trials/brain-imaging-attention-and-auditory-processing-in-schizophrenia-123331https://curecurrent.com/trials/randomized-controlled-trial-rct-of-a-motivational-decision-support-system-123332https://curecurrent.com/trials/transcranial-alternating-current-stimulation-tacs-for-cognitive-impairments-in-patients-with-schizophrenia-123333https://curecurrent.com/trials/efficiency-study-to-investigate-blonanserin-in-treatment-of-schizophrenia-when-compared-with-risperidone-123334https://curecurrent.com/trials/staccato-loxapine-single-dose-pk-123335https://curecurrent.com/trials/a-comparison-of-cognitive-training-approaches-in-psychotic-disorders-123336https://curecurrent.com/trials/safety-and-efficacy-of-cariprazine-in-schizophrenia-123337https://curecurrent.com/trials/remote-cognitive-remediation-123338https://curecurrent.com/trials/study-of-preladenant-for-the-treatment-of-antipsychotic-induced-movement-disorders-in-participants-with-schizophrenia-st-123339https://curecurrent.com/trials/monotherapy-brexpiprazole-opc-34712-trial-in-the-treatment-of-adults-with-schizophrenia-with-impulsivity-123340https://curecurrent.com/trials/person-centered-psychosis-care-an-educational-intervention-123341https://curecurrent.com/trials/study-of-repetitive-transcranial-magnetic-stimulation-in-the-treatment-of-cognitive-impairment-in-schizophrenia-123342https://curecurrent.com/trials/safety-and-efficacy-of-cariprazine-in-patients-with-schizophrenia-123343https://curecurrent.com/trials/randomized-double-blind-placebo-controlled-multi-center-and-tolerability-of-rbp-7000-in-schizophrenia-patients-123344https://curecurrent.com/trials/effects-of-pilates-exercise-program-in-patients-with-schizophrenia-123345https://curecurrent.com/trials/multiple-ascending-dose-study-of-the-safety-tolerability-pharmacokinetic-efficacy-123346https://curecurrent.com/trials/safety-tolerability-and-pharmacokinetics-of-oms643762-in-psychiatrically-stable-schizophrenia-subjects-123347https://curecurrent.com/trials/evaluation-of-the-functional-remission-occurrence-and-predictive-factors-in-schizophrenia-123348https://curecurrent.com/trials/touchscreen-based-cognitive-tests-in-healthy-volunteers-123349https://curecurrent.com/trials/adjuvant-treatment-with-a-glycine-uptake-inhibitor-in-participants-with-negative-symptoms-of-schizophrenia-p05695-mk-843-123350https://curecurrent.com/trials/the-effects-of-bimodal-tdcs-on-illness-severity-insight-functional-outcomes-neurocognition-and-hrv-in-schizophrenia-123351https://curecurrent.com/trials/do-consumer-providers-enhance-recovery-123352https://curecurrent.com/trials/d-serine-in-schizophrenia-123353https://curecurrent.com/trials/evaluation-of-the-necessity-of-long-term-pharmacological-treatment-with-antipsychotics-in-schizophrenic-patients-123354https://curecurrent.com/trials/characterization-of-emotional-processing-of-information-in-bipolar-disorder-and-schizophrenic-patients-123355https://curecurrent.com/trials/d-serine-treatment-for-tardive-dyskinesia-123356https://curecurrent.com/trials/a-trial-of-cognitive-training-in-schizophrenia-123357https://curecurrent.com/trials/testing-a-new-device-to-advance-the-use-of-social-skills-training-with-mental-health-consumers-and-clinicians-123358https://curecurrent.com/trials/safety-and-tolerability-of-inp105-olanzapine-by-i231-pod-device-nasal-spray-in-healthy-volunteers-snap-101-123359https://curecurrent.com/trials/a-proof-of-concept-study-of-intravenous-sodium-nitroprusside-in-adults-with-symptomatic-schizophrenia-123360https://curecurrent.com/trials/long-term-study-of-rbp-7000-in-the-treatment-of-subjects-with-schizophrenia-123361https://curecurrent.com/trials/clinical-trial-of-tolcapone-for-cognition-in-schizophrenia-123362https://curecurrent.com/trials/minocycline-augmentation-to-clozapine-123363https://curecurrent.com/trials/a-long-term-safety-study-of-alks-9072-also-known-as-alks-9070-123364https://curecurrent.com/trials/varenicline-effects-in-schizophrenic-smokers-123365https://curecurrent.com/trials/feasibility-and-relevance-of-high-intensity-functional-training-in-patients-with-first-episode-psychosis-123366https://curecurrent.com/trials/the-effects-of-progressive-muscle-relaxation-therapy-in-patients-with-schizophrenia-123367https://curecurrent.com/trials/the-effect-of-hawthorn-on-lipoprotein-cholesterol-ratio-in-schizophrenics-with-antipsychotics-123368https://curecurrent.com/trials/study-investigating-the-safety-and-tolerability-of-multiple-doses-of-pf-02545920-in-subjects-with-schizophrenia-123369https://curecurrent.com/trials/comparison-of-combination-olanzapine-lithium-or-chlorpromazine-lithium-in-treatment-of-first-manic-episode-with-psychoti-123370https://curecurrent.com/trials/combination-of-dronabinol-and-clonidine-for-cannabis-dependence-in-patients-with-schizophrenia-123371https://curecurrent.com/trials/a-study-of-alks-9072-in-subjects-with-chronic-stable-schizophrenia-123372https://curecurrent.com/trials/an-open-label-study-of-aripiprazole-lauroxil-in-subjects-with-stable-schizophrenia-123373https://curecurrent.com/trials/longitudinal-effect-of-electroconvulsive-therapy-on-schizophrenia-and-bipolar-disorder-a-mri-study-123374https://curecurrent.com/trials/a-novel-treatment-approach-for-self-stigma-in-first-episode-psychosis-123375https://curecurrent.com/trials/cognitive-remediation-of-autobiographical-memory-in-schizophrenia-using-sensecam-123376https://curecurrent.com/trials/prospective-cytochrome-p450-genotyping-and-clinical-outcomes-in-patients-with-psychosis-123377https://curecurrent.com/trials/an-open-trial-of-allopurinol-in-patients-with-poorly-responsive-schizophrenia-123378https://curecurrent.com/trials/predictors-of-persistence-in-patients-with-schizophrenia-treated-with-once-monthly-aripiprazole-in-spain-123379https://curecurrent.com/trials/a-study-to-examine-the-safety-tolerability-and-pharmacokinetics-of-pf-02545920-in-psychiatrically-stable-subjects-with-s-123380https://curecurrent.com/trials/linagliptin-in-schizophrenia-patients-123381https://curecurrent.com/trials/a-trial-of-folate-with-b12-in-patients-with-schizophrenia-with-residual-symptoms-in-ethiopia-123382https://curecurrent.com/trials/open-label-study-to-assess-usability-of-the-medical-information-device-1-mind1-system-in-adults-with-schizophrenia-on-or-123383https://curecurrent.com/trials/mindfulness-psychoeducation-program-for-schizophrenia-123384https://curecurrent.com/trials/personalised-cognitive-remediation-therapy-pcrt-123385https://curecurrent.com/trials/cognitive-remediation-therapy-crt-in-adolescents-with-eos-123386https://curecurrent.com/trials/evaluating-the-efficacy-of-a-late-life-schizophrenia-integrated-care-pathway-to-treat-acute-psychotic-symptoms-123387https://curecurrent.com/trials/trial-of-treatment-for-internalized-stigma-in-schizophrenia-123388https://curecurrent.com/trials/can-imagination-change-upsetting-memories-of-trauma-123389https://curecurrent.com/trials/mobile-enhancement-of-motivation-in-schizophrenia-123390https://curecurrent.com/trials/recruitment-of-patients-through-invitation-letters-123391https://curecurrent.com/trials/a-study-of-the-effectiveness-of-cognitive-adaptation-training-in-early-intervention-for-psychosis-123392https://curecurrent.com/trials/study-of-vitamin-d-in-the-severely-mentally-ill-123393https://curecurrent.com/trials/prevention-of-weight-gain-and-dyslipidemia-by-green-tea-in-patients-initiating-therapy-with-olanzapine-123394https://curecurrent.com/trials/schizophrenia-for-life-a-registry-and-interview-study-among-elderly-with-lifelong-schizophrenia-123395https://curecurrent.com/trials/treatment-of-mania-symptoms-with-drug-therapy-123396https://curecurrent.com/trials/preventing-relapse-in-schizophrenia-oral-antipsychotics-compared-to-injectables-evaluating-efficacy-123397https://curecurrent.com/trials/a-study-of-cariprazine-in-the-prevention-of-relapse-of-symptoms-in-participants-with-schizophrenia-123398https://curecurrent.com/trials/imaging-cannabinoid-cb1-receptors-in-schizophrenia-123399https://curecurrent.com/trials/e-cigarettes-to-promote-smoking-reduction-among-individuals-with-schizophrenia-123400https://curecurrent.com/trials/decision-support-for-smoking-cessation-in-young-adults-with-severe-mental-illness-123401https://curecurrent.com/trials/a-study-of-alks-3831-in-adults-with-acute-exacerbation-of-schizophrenia-the-enlighten-1-study-123402https://curecurrent.com/trials/from-prevention-to-community-integration-ipcst-for-severe-mental-illness-in-chinese-communities-hong-kong-and-beijing-123403https://curecurrent.com/trials/effects-of-atypical-antipsychotic-and-valproate-combination-therapy-on-glucose-and-lipid-metabolism-in-schizophrenia-123404https://curecurrent.com/trials/direct-measurements-of-cardiometabolic-risk-in-treated-schizophrenia-patients-123405https://curecurrent.com/trials/telmisartan-as-an-adjunctive-treatment-for-metabolic-problems-in-patients-with-schizophrenia-123406https://curecurrent.com/trials/feasibility-and-acceptability-of-a-smartphone-app-to-assess-early-warning-signs-of-psychosis-relapse-123407https://curecurrent.com/trials/systematic-evaluation-of-antiviral-medication-in-schizophrenia-123408https://curecurrent.com/trials/study-to-determine-the-pharmacokinetics-safety-tolerability-of-aripiprazole-in-adults-with-schizophrenia-123409https://curecurrent.com/trials/augmentation-of-neuronal-network-plasticity-in-schizophrenia-123410https://curecurrent.com/trials/efficacy-and-safety-study-for-cognitive-deficits-in-adult-subjects-with-schizophrenia-123411https://curecurrent.com/trials/safety-and-efficacy-study-for-cognitive-deficits-in-adult-subjects-with-schizophrenia-123412https://curecurrent.com/trials/exercise-and-cognitive-training-123413https://curecurrent.com/trials/social-cognition-training-in-schizophrenia-123414https://curecurrent.com/trials/an-inpatient-study-of-the-efficacy-safety-and-tolerability-of-pf-02545920-in-the-treatment-of-acute-exacerbation-of-schi-123415https://curecurrent.com/trials/using-motivational-techniques-to-increase-levels-of-physical-activity-in-long-term-psychiatric-inpatient-wards-123416https://curecurrent.com/trials/berberine-effect-on-cytokine-crp-metabolic-disturbance-as-an-adjunctive-therapy-in-schizophrenia-patients-123417https://curecurrent.com/trials/optimizing-response-in-psychosis-study-123418https://curecurrent.com/trials/optimization-of-treatment-and-management-of-schizophrenia-in-europe-123419https://curecurrent.com/trials/cognitive-remediation-for-first-episode-of-psychosis-patients-123420https://curecurrent.com/trials/salsalate-as-an-adjunctive-treatment-for-patients-with-schizophrenia-123421https://curecurrent.com/trials/social-cognition-assessment-in-young-adults-123422https://curecurrent.com/trials/functional-neuroimaging-effects-of-cognitive-remediation-training-123423https://curecurrent.com/trials/promoting-physical-activity-in-people-with-schizophrenia-123424https://curecurrent.com/trials/long-term-safety-and-efficacy-of-abt-126-in-subjects-with-schizophrenia-an-extension-study-for-subjects-completing-study-123425https://curecurrent.com/trials/the-effects-of-tdcs-on-auditory-hallucination-insight-neurocognitive-function-and-hrv-in-patients-with-schizophrenia-123426https://curecurrent.com/trials/the-effect-of-transcranial-direct-current-stimulation-on-human-brains-a-neuroimaging-study-123427https://curecurrent.com/trials/stimulation-to-improve-auditory-hallucinations-123428https://curecurrent.com/trials/transcranial-direct-current-stimulation-influences-on-cognitive-inhibition-in-schizophrenia-123429https://curecurrent.com/trials/motivation-and-executive-control-in-schizophrenia-123430https://curecurrent.com/trials/berberine-treat-metabolic-syndrome-in-schizophrenia-123431https://curecurrent.com/trials/a-shared-decision-making-training-for-inpatients-with-schizophrenia-123432https://curecurrent.com/trials/correlation-between-clinical-deterioration-in-schizophrenic-patients-and-hair-cortisol-levels-123433https://curecurrent.com/trials/influence-of-amphetamine-induced-sensitization-on-dopamine-synthesis-and-release-123434https://curecurrent.com/trials/cognitive-behavior-therapy-for-patients-with-psychoses-123435https://curecurrent.com/trials/effects-of-physical-activity-in-psychosis-123436https://curecurrent.com/trials/therapeutic-efficacy-of-transcranial-magnetic-stimulation-in-schizophrenia-123437https://curecurrent.com/trials/use-of-galantamine-and-cdp-choline-citicoline-to-treat-adults-with-schizophrenia-123438https://curecurrent.com/trials/very-low-nicotine-cigarettes-in-smokers-with-schizophrenia-123439https://curecurrent.com/trials/a-d1-agonist-for-working-memory-123440https://curecurrent.com/trials/assessment-of-cannabis-craving-in-schizophrenia-using-virtual-reality-123441https://curecurrent.com/trials/brain-circuits-in-schizophrenia-and-smoking-123442https://curecurrent.com/trials/effects-of-nicotine-on-areas-of-impaired-and-preserved-functioning-in-schizophrenia-123443https://curecurrent.com/trials/brain-functions-underlying-visuospatial-attention-deficits-in-schizophrenia-123444https://curecurrent.com/trials/neuroimaging-studies-of-neurophysiological-phenotypes-in-schizophrenia-123445https://curecurrent.com/trials/folate-supplementation-in-schizophrenia-123446https://curecurrent.com/trials/clonazepam-effects-on-brain-oscillations-and-cognition-in-schizophrenia-123447https://curecurrent.com/trials/transcranial-direct-current-stimulation-tdcs-in-treatment-refractory-auditory-hallucinations-123448https://curecurrent.com/trials/short-term-working-memory-and-executive-training-123449https://curecurrent.com/trials/evaluation-of-a-visual-remediation-intervention-for-schizophrenia-123450https://curecurrent.com/trials/include-using-lived-experience-to-improve-mental-health-diagnosis-v1-123451https://curecurrent.com/trials/pharmacokinetics-and-safety-studies-of-esomeprazole-use-in-schizophrenia-patients-123452https://curecurrent.com/trials/integrated-metacognitive-therapy-in-first-episode-psychosis-123453https://curecurrent.com/trials/plantar-sensation-balance-risk-of-falling-and-gait-in-patients-with-schizophrenia-123454https://curecurrent.com/trials/risperidone-and-desipramine-in-alcohol-use-and-schizophrenia-123455https://curecurrent.com/trials/evaluation-and-validation-of-social-cognition-battery-to-characterize-schizophrenic-patients-functioning-123456https://curecurrent.com/trials/normal-and-abnormal-erp-during-tom-and-emotional-conflicts-in-schizophrenia-123457https://curecurrent.com/trials/alcoholism-and-schizophrenia-effects-of-clozapine-123458https://curecurrent.com/trials/efficacy-of-quetiapine-in-the-treatment-of-patients-with-schizophrenia-and-a-comorbid-substance-use-disorder-123459https://curecurrent.com/trials/transcranial-direct-current-stimulation-for-hallucinations-in-first-episode-schizophrenia-123460https://curecurrent.com/trials/cannabidiol-as-a-different-type-of-an-antipsychotic-drug-delivery-and-interaction-study-123461https://curecurrent.com/trials/effect-of-n-acetylcysteine-on-brain-glutamate-123462https://curecurrent.com/trials/improving-cognition-in-schizophrenia-using-tdcs-123463https://curecurrent.com/trials/clozapine-induced-hypersalivation-feasibility-trial-123464https://curecurrent.com/trials/pharmacovigilance-in-gerontopsychiatric-patients-123465https://curecurrent.com/trials/scit-versus-tar-for-outpatients-with-schizophrenia-123466https://curecurrent.com/trials/repetitive-transcranial-magnetic-stimulation-for-the-treatment-of-negative-symptoms-in-schizophrenia-patients-123467https://curecurrent.com/trials/computer-aided-learning-for-managing-stress-123468https://curecurrent.com/trials/study-of-immunotherapy-in-autoantibody-positive-psychosis-123469https://curecurrent.com/trials/pilot-trial-of-valproate-as-adjunctive-treatment-for-toxoplasma-gondii-infection-in-early-course-schizophrenia-123470https://curecurrent.com/trials/perception-of-facial-emotions-in-schizophrenia-and-22q11-deletion-syndrome-123471https://curecurrent.com/trials/d-cycloserine-augmentation-of-cognitive-remediation-in-schizophrenia-123472https://curecurrent.com/trials/assessment-of-adverse-events-in-a-naive-pediatric-population-treated-with-an-antipsychotic-123473https://curecurrent.com/trials/gender-differences-in-social-cognition-in-patients-with-schizophrenia-of-recent-diagnosis-and-healthy-controls-subjects-123474https://curecurrent.com/trials/daaoi-2-add-on-treatment-for-treatment-resistant-schizophrenia-123475https://curecurrent.com/trials/virtual-reality-therapy-for-treatment-resistant-auditory-hallucinations-in-schizophrenia-123476https://curecurrent.com/trials/characterization-of-the-motivational-deficit-in-schizophrenia-and-depression-123477https://curecurrent.com/trials/prospective-pharmacogenetic-testing-and-clinical-outcomes-in-patients-with-early-phase-psychosis-123478https://curecurrent.com/trials/a-pilot-trial-of-curcumin-effects-on-cognition-in-schizophrenia-123479https://curecurrent.com/trials/long-acting-paliperidone-palmitate-injection-and-olanzapine-for-schizophrenia-123480https://curecurrent.com/trials/facilitation-of-nmda-receptor-function-in-patients-with-schizophrenia-and-co-morbid-alcoholism-123481https://curecurrent.com/trials/computerized-cognitive-training-for-schizophrenia-in-brazil-123482https://curecurrent.com/trials/safety-and-tolerability-study-of-single-dose-administration-of-brexpiprazole-in-adult-subjects-with-schizophrenia-123483https://curecurrent.com/trials/mirror-image-study-of-paliperidone-palmitate-and-risperidone-long-acting-injection-123484https://curecurrent.com/trials/withania-somnifera-an-immunomodulator-and-anti-inflammatory-agent-for-schizophrenia-123485https://curecurrent.com/trials/staccato-loxapine-in-agitation-proof-of-concept-123486https://curecurrent.com/trials/psycho-social-support-on-mental-health-and-hope-of-adolescents-affected-by-earthquake-in-nepal-123487https://curecurrent.com/trials/neurophysiological-targets-for-cognitive-training-in-schizophrenia-123488https://curecurrent.com/trials/a-study-of-varenicline-for-prevention-of-relapse-to-smoking-in-patients-with-schizophrenia-or-bipolar-disorder-123489https://curecurrent.com/trials/double-blind-randomized-3-week-inpatient-study-to-evaluate-the-safety-efficacy-of-pf-02545920-compared-with-placebo-123490https://curecurrent.com/trials/using-d-cycloserine-to-enhance-the-benefits-of-cognitive-behavioral-therapy-for-schizophrenia-123491https://curecurrent.com/trials/collaborative-shared-care-to-improve-psychosis-outcome-123492https://curecurrent.com/trials/add-on-methotrexate-for-the-treatment-of-schizophrenia-123493https://curecurrent.com/trials/enhancing-cognitive-training-through-exercise-after-a-first-schizophrenia-episode-123494https://curecurrent.com/trials/peer-support-for-increasing-physical-activity-in-people-with-serious-mental-illnesses-123495https://curecurrent.com/trials/functional-brain-imaging-and-employment-in-first-episode-psychotic-patients-treated-with-risperdal-123496https://curecurrent.com/trials/varenicline-for-cognitive-deficits-and-cigarette-smoking-in-schizophrenia-efficacy-and-predictors-123497https://curecurrent.com/trials/safety-and-tolerability-of-varenicline-in-schizophrenia-satova-123498https://curecurrent.com/trials/risperidone-la-heathcare-resource-study-123499https://curecurrent.com/trials/a-study-to-assess-the-pharmacomri-effects-of-aut00206-in-healthy-males-123500https://curecurrent.com/trials/a-multiple-dose-study-of-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-abt-288-in-stable-subjects-with-sc-123501https://curecurrent.com/trials/assessment-of-intra-subject-variability-in-the-bioavailability-of-chlorpromazine-hydrochloride-123502https://curecurrent.com/trials/galantamine-and-memantine-combination-for-cognitive-impairments-in-schizophrenia-123503https://curecurrent.com/trials/nbi-98854-for-the-treatment-of-tardive-dyskinesia-in-subjects-with-schizophrenia-or-schizoaffective-disorder-kinect-stud-123504https://curecurrent.com/trials/study-to-evaluate-the-efficacy-and-safety-of-gsk239512-in-schizophrenia-123505https://curecurrent.com/trials/perceptual-deficits-in-schizophrenia-123506https://curecurrent.com/trials/cognitive-therapy-for-distressing-visual-hallucinations-a-pilot-study-123507https://curecurrent.com/trials/joint-crisis-plans-or-crisis-cards-for-people-with-severe-mental-disorders-to-reduce-coercion-in-psychiatric-care-123508https://curecurrent.com/trials/improving-medication-adherence-among-people-with-schizophrenia-through-the-use-of-2-way-pagers-123509https://curecurrent.com/trials/a-study-to-investigate-the-efficacy-safety-and-tolerability-of-four-different-doses-of-bi-409306-compared-to-placebo-giv-123510https://curecurrent.com/trials/the-partners-genetics-collaborative-study-of-schizophrenia-123511https://curecurrent.com/trials/manual-dexterity-and-oculomotor-control-in-schizophrenia-123512https://curecurrent.com/trials/csc-ondemand-an-innovative-online-learning-platform-for-implementing-coordinated-specialty-care-123513https://curecurrent.com/trials/evaluating-genetic-risk-factors-for-childhood-onset-schizophrenia-123514https://curecurrent.com/trials/clozapine-plasma-levels-and-the-relationship-to-the-genetic-polymorphism-in-shizophrenic-patients-123515https://curecurrent.com/trials/visual-information-processing-in-schizophrenia-patients-with-visual-hallucinations-123516https://curecurrent.com/trials/screening-for-childhood-onset-psychotic-disorders-123517https://curecurrent.com/trials/using-mobile-technology-to-enhance-early-psychosis-treatment-delivery-123518https://curecurrent.com/trials/internal-monitoring-of-eye-movement-in-schizophrenia-123519https://curecurrent.com/trials/pilot-study-of-atomoxetine-to-enhance-cognition-in-patients-with-schizophrenia-123520https://curecurrent.com/trials/measuring-time-windows-in-patients-with-schizophrenia-and-healthy-controls-123521https://curecurrent.com/trials/pain-and-schizophrenia-123522https://curecurrent.com/trials/modafinil-for-treatment-of-cognitive-dysfunction-in-schizophrenia-123523https://curecurrent.com/trials/modafinil-effects-on-cognition-in-schizophrenia-patients-123524https://curecurrent.com/trials/influence-of-environmental-factors-and-schizophrenia-123525https://curecurrent.com/trials/ziprasidone-vs-standard-therapy-for-agitated-patients-in-the-ed-123526https://curecurrent.com/trials/emotional-intelligence-in-schizophrenia-and-bipolar-i-disorder-123527https://curecurrent.com/trials/researching-the-effectiveness-of-acceptance-based-coping-during-hospitalization-123528https://curecurrent.com/trials/insight-in-persons-presenting-schizophrenia-or-related-troubles-during-hospitalization-in-psychiatry-123529https://curecurrent.com/trials/targeting-a-genetic-mutation-in-glycine-metabolism-with-d-cycloserine-123530https://curecurrent.com/trials/neurobiology-of-a-mutation-in-glycine-metabolism-in-psychotic-disorders-123531https://curecurrent.com/trials/a-study-to-assess-the-pharmacokinetics-safety-and-tolerability-of-paliperidone-palmitate-in-patients-with-schizophrenia-123532https://curecurrent.com/trials/smartphone-applications-youth-with-early-psychosis-in-community-outpatient-settings-123533https://curecurrent.com/trials/self-management-and-recovery-technology-psychosocial-intervention-trial-123534https://curecurrent.com/trials/effects-of-a-psycho-corporal-training-on-postural-and-cognitive-dual-task-performances-in-patients-with-schizophrenia-123535https://curecurrent.com/trials/kuvan-in-people-with-schizophrenia-and-schizoaffective-disorder-123536https://curecurrent.com/trials/rtms-treatment-for-cannabis-use-disorders-in-psychosis-123537https://curecurrent.com/trials/study-on-psychoeducation-enhancing-results-of-adherence-in-schizophrenia-123538https://curecurrent.com/trials/work-activity-augmented-by-cognitive-rehabilitation-for-schizophrenia-123539https://curecurrent.com/trials/participatory-video-as-a-recovery-oriented-intervention-in-early-psychosis-123540https://curecurrent.com/trials/mindfulness-group-based-intervention-for-early-psychosis-a-pilot-study-123541https://curecurrent.com/trials/integrated-psychological-therapy-for-chronic-schizophrenia-123542https://curecurrent.com/trials/integrated-supported-employment-in-mainland-china-123543https://curecurrent.com/trials/a-study-of-rtms-for-cognitive-deficits-in-chronic-patients-with-schizophrenia-123544https://curecurrent.com/trials/l-arginine-in-treatment-as-usual-in-schizophrenia-123545https://curecurrent.com/trials/psychosis-associated-neuroinflammation-in-schizophrenia-123546https://curecurrent.com/trials/transcranial-direct-current-stimulation-tdcs-as-a-treatment-for-cigarette-craving-and-cognitive-deficits-in-schizophreni-123547https://curecurrent.com/trials/effects-of-psychoeducation-of-relatives-to-patients-with-serious-mental-illness-123548https://curecurrent.com/trials/an-extension-of-a-long-term-safety-study-of-alks-9072-also-known-as-alks-9070-123549https://curecurrent.com/trials/the-effects-of-ketamine-and-guanfacine-on-working-memory-in-healthy-subjects-123550https://curecurrent.com/trials/individual-acceptance-and-commitment-therapy-act-for-smoking-cessation-for-schizophrenic-patients-123551https://curecurrent.com/trials/spect-study-with-sb-773812-in-schizophrenic-patients-123552https://curecurrent.com/trials/schizophrenia-study-in-adults-123553https://curecurrent.com/trials/d-serine-for-the-schizophrenia-prodrome-123554https://curecurrent.com/trials/guided-dose-reduction-of-antipsychotic-in-patients-with-psychosis-in-remitted-states-123555https://curecurrent.com/trials/nbi-98854-for-the-treatment-of-tardive-dyskinesia-in-subjects-with-schizophrenia-or-schizoaffective-disorder-123556https://curecurrent.com/trials/tdcs-to-enhance-cognitive-training-in-schizophrenia-123557https://curecurrent.com/trials/a-healthy-volunteer-study-to-assess-the-relative-bioavailability-of-2-forms-of-sb773812-tablets-123558https://curecurrent.com/trials/early-medication-discontinuation-and-long-term-clinical-outcome-in-fep-123559https://curecurrent.com/trials/first-time-in-human-study-with-gsk1018921-123560https://curecurrent.com/trials/effects-of-the-drug-ketoconazole-on-how-the-body-handles-the-drug-sb773812-123561https://curecurrent.com/trials/biomarkers-in-schizophrenia-123562https://curecurrent.com/trials/evaluation-of-metamemory-using-a-semantic-construction-strategy-in-patients-with-schizophrenia-123563https://curecurrent.com/trials/staccato-loxapine-in-agitated-patients-with-schizophrenia-123564https://curecurrent.com/trials/cognitive-remediation-therapy-within-a-secure-forensic-setting-123565https://curecurrent.com/trials/treating-social-cognition-with-theta-burst-stimulation-a-pilot-sudy-123566https://curecurrent.com/trials/safety-tolerability-and-pharmacokinetics-of-gsk1034702-in-healthy-subjects-123567https://curecurrent.com/trials/cognitive-skills-training-using-computer-for-patients-with-severe-mental-illness-123568https://curecurrent.com/trials/demographic-and-clinical-predictors-of-persistence-in-patients-treated-with-aripiprazole-once-monthly-in-italy-123569https://curecurrent.com/trials/enhancing-motivation-to-quit-smoking-in-smokers-with-serious-mental-illness-123570https://curecurrent.com/trials/positron-emission-tomography-pet-study-to-describe-the-relationship-between-plasma-concentrations-and-brain-gly-t1-occup-123571https://curecurrent.com/trials/study-to-evaluate-d2-receptor-occupancy-following-single-intravenous-administration-of-ati-9242-123572https://curecurrent.com/trials/predictors-of-treatment-outcome-for-smokers-with-and-without-schizophrenia-123573https://curecurrent.com/trials/cognitive-behavioural-therapy-social-functioning-in-adolescence-with-recent-onset-schizophrenia-123574https://curecurrent.com/trials/pharmacokinetics-and-tolerability-study-of-risperidone-ism-in-schizophrenia-123575https://curecurrent.com/trials/daily-intranasal-oxytocin-for-childhood-onset-schizophrenia-123576https://curecurrent.com/trials/first-time-in-human-study-ftih-with-positron-emission-tomography-pet-123577https://curecurrent.com/trials/social-isolation-and-loneliness-in-older-people-123578https://curecurrent.com/trials/n-acetyl-cysteine-nac-in-early-phase-schizophrenia-spectrum-psychosis-123579https://curecurrent.com/trials/neuropsychological-evaluation-of-psychiatric-and-neurological-patients-123580https://curecurrent.com/trials/fmri-study-of-nicotinic-effect-on-neurophysiology-of-schizophrenia-123581https://curecurrent.com/trials/velocardiofacial-vcfs-22q11-2-digeorge-syndrome-study-123582https://curecurrent.com/trials/nicotinic-receptor-density-in-smoking-and-nonsmoking-schizophrenics-123583https://curecurrent.com/trials/eye-blink-response-in-healthy-volunteers-and-adults-with-schizophrenia-123584https://curecurrent.com/trials/omega-3-fatty-acids-lovaza-for-second-generation-antipsychotic-associated-hypertriglyceridemia-123585https://curecurrent.com/trials/risk-perception-in-drug-dependent-adults-with-and-without-schizophrenia-123586https://curecurrent.com/trials/timing-of-voluntary-movement-in-patients-with-schizophrenia-123587https://curecurrent.com/trials/a-long-term-extended-treatment-study-of-aripiprazole-in-pediatric-patients-with-schizophrenia-123588https://curecurrent.com/trials/a-short-treatment-study-of-aripiprazole-in-pediatric-patients-with-schizophrenia-123589https://curecurrent.com/trials/a-study-of-ro4917838-in-participants-with-persistent-predominant-negative-symptoms-of-schizophrenia-nn25310-123590https://curecurrent.com/trials/psychosocial-intervention-to-reduce-self-stigma-and-improve-quality-of-life-among-people-with-mental-illness-in-chile-123591https://curecurrent.com/trials/pharmacokinetics-effect-of-food-safety-and-tolerability-of-a-new-tablet-formulation-of-gsk1144814-in-healthy-subjects-123592https://curecurrent.com/trials/a-phase-i-sequential-cohort-dosing-to-determine-maximum-tolerated-dose-in-healthy-male-volunteers-123593https://curecurrent.com/trials/a-repeat-dose-positron-emission-tomography-study-with-gsk1144814-123594https://curecurrent.com/trials/financial-incentives-to-improve-acceptance-of-antipsychotic-injections-123595https://curecurrent.com/trials/event-marker-ingested-to-trigger-event-recorder-3-0-psychiatry-study-123596https://curecurrent.com/trials/effects-of-eszopiclone-on-sleep-and-memory-in-schizophrenia-123597https://curecurrent.com/trials/a-study-to-examine-the-pharmacodynamic-effects-of-gsk1034702-on-neurophysiological-biomarkers-of-cognition-in-nicotine-a-123598https://curecurrent.com/trials/cannabidiol-treatment-of-cognitive-dysfunction-in-schizophrenia-123599https://curecurrent.com/trials/serotonin-1a-agonists-and-cognition-in-schizophrenia-123600https://curecurrent.com/trials/a-study-to-evaluate-the-effects-of-ro5545965-in-participants-with-negative-symptoms-of-schizophrenia-treated-with-antips-123601https://curecurrent.com/trials/evaluation-of-qtc-interval-by-continuous-holter-ecg-recording-in-antipsychotic-drug-treated-patients-with-schizophrenia-123602https://curecurrent.com/trials/high-dose-oral-ziprasidone-versus-conventional-dosing-in-participants-with-residual-schizophrenia-symptoms-123603https://curecurrent.com/trials/cerebellar-rtms-for-the-treatment-of-schizophrenic-patients-123604https://curecurrent.com/trials/nicotinic-receptors-and-schizophrenia-123605https://curecurrent.com/trials/cognitive-behavior-therapy-and-work-outcome-123606https://curecurrent.com/trials/evaluation-of-stroop-effect-in-patients-with-schizophrenia-123607https://curecurrent.com/trials/electronic-cigarettes-in-smokers-with-mental-illness-123608https://curecurrent.com/trials/electroconvulsive-therapy-in-clozapine-refractory-schizophrenia-123609https://curecurrent.com/trials/resource-oriented-music-therapy-for-psychiatric-patients-with-low-therapy-motivation-123610https://curecurrent.com/trials/employment-outcomes-after-vocational-training-123611https://curecurrent.com/trials/relationship-between-neurotransmitter-receptor-polymorphisms-plasma-concentrations-and-clinical-response-to-clozapine-123612https://curecurrent.com/trials/rise-rehabilitation-intervention-for-people-with-schizophrenia-in-ethiopia-123613https://curecurrent.com/trials/safety-and-tolerability-study-of-oral-opc-34712-as-maintenance-treatment-in-adults-with-schizophrenia-123614https://curecurrent.com/trials/d-serine-treatment-of-negative-symptoms-and-cognitive-deficits-in-schizophrenia-123615https://curecurrent.com/trials/evaluation-of-executive-function-with-virtual-reality-among-people-with-schizophrenia-123616https://curecurrent.com/trials/50-hz-vs-25-hz-magnetic-seizure-therapy-for-schizophrenia-123617https://curecurrent.com/trials/transcranial-direct-current-stimulation-as-treatment-for-auditory-hallucinations-123618https://curecurrent.com/trials/evaluation-of-tak-058-and-ondansetron-on-p50-auditory-gating-in-participants-with-stable-schizophrenia-123619https://curecurrent.com/trials/the-effects-of-nicotine-on-cognition-in-schizophrenia-123620https://curecurrent.com/trials/anomalous-self-experience-in-first-episode-psychosis-a-six-year-follow-up-study-123621https://curecurrent.com/trials/the-effect-of-a-community-based-lai-treated-management-model-on-the-violence-risk-of-patients-with-schizophrenia-123622https://curecurrent.com/trials/pilot-study-comparing-effects-of-xanomeline-alone-to-xanomeline-plus-trospium-123623https://curecurrent.com/trials/quantifying-abnormalities-in-cortical-activation-associated-with-auditory-hallucinations-using-functional-magnetic-reson-123624https://curecurrent.com/trials/pediatric-schizophrenia-efficacy-and-safety-study-123625https://curecurrent.com/trials/oxytocin-treatment-of-schizophrenia-123626https://curecurrent.com/trials/vitamin-d-for-schizophrenia-123627https://curecurrent.com/trials/efficacy-of-cognitive-remediation-in-patients-with-schizophrenia-or-schizoaffective-disorder-stabilized-on-lurasidone-123628https://curecurrent.com/trials/cognitive-remediation-in-youth-at-risk-of-serious-mental-illness-123629https://curecurrent.com/trials/patient-guided-psychiatric-admissions-123630https://curecurrent.com/trials/a-study-to-assess-the-clinical-utility-of-antipsychotic-medication-levels-in-plasma-as-determined-by-liquid-chromatograp-123631https://curecurrent.com/trials/treatment-effects-from-aerobic-endurance-training-and-maximal-strength-training-in-patients-suffering-from-schizophrenia-123632https://curecurrent.com/trials/study-of-the-effects-of-mecamylamine-and-varenicline-in-schizophrenia-123633https://curecurrent.com/trials/to-demonstrate-the-relative-bioequivalency-of-generic-haloperidol-tablets-versus-haldol-in-normal-volunteers-123634https://curecurrent.com/trials/brexpiprazole-in-patients-with-schizophrenia-123635https://curecurrent.com/trials/a-study-to-compare-the-pharmacokinetics-profile-of-dwczp-tablet-100mg-and-clozaril-tablet-100mg-123636https://curecurrent.com/trials/add-on-simvastatin-in-schizophrenia-trial-123637https://curecurrent.com/trials/improving-care-and-reducing-cost-study-123638https://curecurrent.com/trials/sb-773812-administered-in-adults-with-schizophrenia-123639https://curecurrent.com/trials/computerised-interventions-for-thinking-and-anxiety-in-delusions-citadel-trial-123640https://curecurrent.com/trials/aripiprazole-once-monthly-versus-paliperidone-palmitate-in-adult-patients-with-schizophrenia-123641https://curecurrent.com/trials/aripiprazole-once-monthly-in-patients-with-schizophrenia-123642https://curecurrent.com/trials/brexpiprazole-in-patients-with-acute-schizophrenia-123643https://curecurrent.com/trials/effectiveness-of-tropisetron-plus-risperidone-for-improving-cognitive-and-perceptual-disturbances-in-schizophrenia-123644https://curecurrent.com/trials/social-cognition-intervention-123645https://curecurrent.com/trials/family-directed-cognitive-adaptation-program-for-individuals-with-schizophrenia-123646https://curecurrent.com/trials/comparative-study-of-aripiprazole-quetiapine-and-ziprasidone-in-the-treatment-of-first-episode-nonaffective-psychosis-123647https://curecurrent.com/trials/3-year-follow-up-of-clinical-outcome-after-antipsychotic-treatment-discontinuation-in-psychosis-individuals-123648https://curecurrent.com/trials/comparative-study-of-aripiprazole-quetiapine-and-ziprasidone-in-treatment-of-first-episode-psychosis-3-year-follow-up-123649https://curecurrent.com/trials/neurocognitive-effectiveness-in-treatment-of-first-episode-non-affective-psychosis-1-year-follow-up-123650https://curecurrent.com/trials/a-study-to-determine-the-safety-tolerability-and-efficacy-nw-3509a-in-patients-with-chronic-schizophrenia-123651https://curecurrent.com/trials/the-immune-system-and-psychiatric-disorders-123652https://curecurrent.com/trials/a-multicenter-study-of-nap-al-108-in-schizophrenia-123653https://curecurrent.com/trials/receptor-occupancy-of-iti-007-using-positron-emission-tomography-pet-in-patients-with-stable-schizophrenia-123654https://curecurrent.com/trials/real-life-assessment-of-abilify-maintena-123655https://curecurrent.com/trials/integration-of-illness-management-and-recovery-within-act-123656https://curecurrent.com/trials/computerized-cognitive-behavioral-therapy-for-auditory-hallucinations-123657https://curecurrent.com/trials/effects-of-rg1068-secretin-on-information-processing-in-schizophrenia-123658https://curecurrent.com/trials/transcranial-direct-current-stimulation-tdcs-and-hallucinations-in-schizophrenia-123659https://curecurrent.com/trials/crt-guanfacine-for-spd-123660https://curecurrent.com/trials/forensic-assertive-community-treatment-an-emerging-model-of-service-delivery-123661https://curecurrent.com/trials/cognitive-remediation-therapy-in-schizophrenia-effects-on-bdnf-levels-123662https://curecurrent.com/trials/arithmetic-training-with-the-kumon-method-for-cognition-in-schizophrenia-123663https://curecurrent.com/trials/antipsychotic-effects-of-sorghum-bicolor-jobelyn-in-the-treatment-of-schizophrenia-123664https://curecurrent.com/trials/a-study-to-evaluate-efficacy-and-safety-of-bitopertin-in-participants-with-persistent-predominant-negative-symptoms-of-s-123665https://curecurrent.com/trials/open-label-study-of-flexible-dose-paliperidone-er-extended-release-to-treat-adolescent-schizophrenia-123666https://curecurrent.com/trials/pregnenolone-for-cognitive-and-negative-symptoms-in-schizophrenia-123667https://curecurrent.com/trials/conversion-to-antipsychotic-monotherapy-123668https://curecurrent.com/trials/specialized-treatment-early-in-psychosis-step-123669https://curecurrent.com/trials/omega-3-dietary-supplements-in-schizophrenia-123670https://curecurrent.com/trials/pk-safety-and-tolerability-study-of-rbp-7000-of-different-molecular-weight-polymer-in-subjects-with-schizophrenia-123671https://curecurrent.com/trials/coronary-artery-disease-in-patients-suffering-from-schizophrenia-123672https://curecurrent.com/trials/effects-of-varenicline-on-smoking-lapse-in-smokers-with-and-without-schizophrenia-123673https://curecurrent.com/trials/continued-early-intervention-for-recent-onset-schizophrenia-123674https://curecurrent.com/trials/culturally-adapted-cognitive-behavior-therapy-for-psychosis-in-pakistan-123675https://curecurrent.com/trials/screening-of-niemann-pick-disease-type-c-in-a-psychiatric-population-123676https://curecurrent.com/trials/efficacy-safety-and-tolerability-of-brexpiprazole-opc-34712-as-maintenance-treatment-in-adults-with-schizophrenia-123677https://curecurrent.com/trials/treatment-of-negative-symptoms-of-schizophrenia-with-transcranial-magnetic-stimulation-tms-123678https://curecurrent.com/trials/nicotine-and-cotinine-levels-in-smokers-with-schizophrenia-and-schizoaffective-disorder-2-123679https://curecurrent.com/trials/treating-nicotine-dependence-in-schizophrenic-individuals-effectiveness-of-bupropion-1-123680https://curecurrent.com/trials/nicotine-patch-for-nicotine-dependence-in-individuals-with-schizophrenia-or-schizoaffective-disorder-1-123681https://curecurrent.com/trials/effects-of-transdermal-nicotine-on-smoking-craving-and-withdrawal-in-people-with-schizophrenia-123682https://curecurrent.com/trials/effect-of-bupropion-on-smoking-behavior-in-smokers-with-schizophrenia-123683https://curecurrent.com/trials/safety-and-effectiveness-of-sustained-release-bupropion-in-treating-individuals-with-schizophrenia-who-smoke-123684https://curecurrent.com/trials/cognitive-enhancement-therapy-for-early-stage-schizophrenia-123685https://curecurrent.com/trials/pregablin-for-anxiety-comorbidity-in-patients-with-schizophrenia-123686https://curecurrent.com/trials/phase-i-study-to-evaluate-the-safety-and-pharmacokinetics-of-oral-doses-of-anvylic-3288-in-healthy-subjects-123687https://curecurrent.com/trials/treatment-of-refractory-auditory-verbal-hallucinations-with-tdcs-in-schizophrenia-123688https://curecurrent.com/trials/electroconvulsive-therapy-for-treatment-refractory-schizophrenia-a-randomized-double-blinded-sham-controlled-study-123689https://curecurrent.com/trials/f17464-in-acute-schizophrenia-trial-123690https://curecurrent.com/trials/magnesium-variations-and-cardiometabolic-risk-in-patients-with-antipsychotic-drugs-123691https://curecurrent.com/trials/to-rescue-cognition-with-valaciclovir-123692https://curecurrent.com/trials/yoga-as-cognitive-remediation-in-schizophrenia-123693https://curecurrent.com/trials/factors-influencing-social-functioning-of-people-with-schizophrenia-123694https://curecurrent.com/trials/upside-down-give-me-the-handle-123695https://curecurrent.com/trials/the-impact-of-a-helplessness-and-recovery-of-an-empowerment-intervention-on-people-diagnosed-with-schizophrenia-findings-123696https://curecurrent.com/trials/cognitive-remediation-and-functional-skills-training-in-schizophrenia-123697https://curecurrent.com/trials/assertive-community-treatment-with-cbt-and-sst-for-schizophrenia-123698https://curecurrent.com/trials/genes-polymorphisms-and-metabolic-effects-of-the-second-generation-antipsychotic-drugs-in-patients-with-schizophrenia-123699https://curecurrent.com/trials/neuroendocrine-and-metabolite-substrates-in-schizophrenia-123700https://curecurrent.com/trials/effects-of-ketamine-and-risperidone-on-cognition-123701https://curecurrent.com/trials/efficacy-of-lu-31-130-in-patients-with-schizophrenia-123702https://curecurrent.com/trials/efficacy-of-lu-31-130-in-patients-with-schizophrenia-123703https://curecurrent.com/trials/safety-study-of-an-antipsychotic-sertindole-to-treat-schizophrenia-123704https://curecurrent.com/trials/safety-and-efficacy-of-zicronapine-in-patients-with-schizophrenia-123705https://curecurrent.com/trials/efficacy-study-exploring-the-effect-of-lu-ae58054-as-augmentation-therapy-in-patients-with-schizophrenia-123706https://curecurrent.com/trials/lurasidone-extended-use-study-123707https://curecurrent.com/trials/multi-disciplinary-treatment-for-patients-experiencing-first-episode-of-psychosis-123708https://curecurrent.com/trials/a-study-of-ro4917838-bitopertin-in-patients-with-acute-exacerbation-of-schizophrenia-123709https://curecurrent.com/trials/a-study-of-the-safety-tolerability-and-pharmacokientics-of-ro5545965-in-patients-with-schizophrenia-on-risperidone-123710https://curecurrent.com/trials/a-study-of-ro4917838-bitopertin-in-patients-with-sub-optimally-controlled-symptoms-of-schizophrenia-wn25306-123711https://curecurrent.com/trials/the-management-of-schizophrenia-in-clinical-practice-mosaic-123712https://curecurrent.com/trials/a-study-of-ro4917838-bitopertin-in-patients-with-sub-optimally-controlled-symptoms-of-schizophrenia-wn25305-123713https://curecurrent.com/trials/tdcs-auditory-hallucinations-in-schizophrenia-123714https://curecurrent.com/trials/an-non-interventional-study-of-patients-with-persistent-symptoms-of-schizophrenia-123715https://curecurrent.com/trials/a-study-of-ro4917838-bitopertin-in-patients-with-persistent-predominant-negative-symptoms-of-schizophrenia-wn25309-123716https://curecurrent.com/trials/a-pet-study-with-ro5545965-in-healthy-male-volunteers-123717https://curecurrent.com/trials/comparison-of-antipsychotics-for-metabolic-problems-in-schizophrenia-or-schizoaffective-disorder-123718https://curecurrent.com/trials/a-non-interventional-study-of-patients-with-persistent-symptoms-of-schizophrenia-to-describe-medical-resource-utilizatio-123719https://curecurrent.com/trials/a-study-of-the-effect-of-ro4917838-on-biomarker-measures-of-cognitive-dysfunction-in-participants-with-schizophrenia-and-123720https://curecurrent.com/trials/effect-of-repetitive-transcranial-magnetic-stimulation-on-resting-state-brain-activity-in-schizophrenia-123721https://curecurrent.com/trials/change-it-is-about-life-123722https://curecurrent.com/trials/optimization-of-treatment-and-management-of-schizophrenia-in-europe-optimise-substudy-site-copenhagen-123723https://curecurrent.com/trials/valacyclovir-augmentation-for-cognitive-and-functional-remediation-in-schizophrenia-123724https://curecurrent.com/trials/extended-specialized-assertive-intervention-for-first-episode-psychosis-123725https://curecurrent.com/trials/a-comparison-of-long-acting-injectable-medications-for-schizophrenia-123726https://curecurrent.com/trials/the-efficacy-and-safety-of-intramuscular-ziprasidone-for-three-days-in-patients-with-psychotic-agitation-123727https://curecurrent.com/trials/safety-blood-levels-and-effects-of-aut00206-123728https://curecurrent.com/trials/antipsychotic-discontinuation-in-high-risk-subjects-123729https://curecurrent.com/trials/a-safety-tolerability-pk-and-pd-study-of-multiple-oral-doses-of-skl15508-in-subjects-with-stable-schizophrenia-123730https://curecurrent.com/trials/validating-three-common-occupational-therapy-assessments-in-participants-with-schizophrenia-123731https://curecurrent.com/trials/low-pulse-amplitude-seizure-therapy-lap-st-study-123732https://curecurrent.com/trials/study-of-an-fda-approved-drug-as-additional-therapy-in-patients-with-schizophrenia-123733https://curecurrent.com/trials/bifrontal-and-bitemporal-electroconvulsive-therapy-ect-in-treatment-of-patients-with-schizophrenia-123734https://curecurrent.com/trials/roflumilast-plus-antipsychotics-proof-of-mechanism-study-in-schizophrenia-123735https://curecurrent.com/trials/randomized-clinical-trial-of-intensive-computer-based-cognitive-remediation-in-recent-onset-schizophrenia-123736https://curecurrent.com/trials/potential-intervention-strategy-with-folic-acid-and-vitamin-b12-in-patients-with-schizophrenia-123737https://curecurrent.com/trials/smoking-relapse-prevention-in-schizophrenia-123738https://curecurrent.com/trials/a-phase-1-safety-study-in-adults-with-schizophrenia-123739https://curecurrent.com/trials/the-assessment-of-movement-disorders-utilizing-live-two-way-video-123740https://curecurrent.com/trials/minocycline-add-on-to-antipsychotics-for-the-treatment-of-negative-and-cognitive-symptoms-in-schizophrenia-123741https://curecurrent.com/trials/effect-of-sarcosine-on-symptomatology-quality-of-life-oxidative-stress-and-glutamatergic-parameters-in-schizophrenia-123742https://curecurrent.com/trials/online-family-support-and-education-for-schizophrenia-123743https://curecurrent.com/trials/milestones-of-adjustment-post-psychosis-123744https://curecurrent.com/trials/comparison-of-aripiprazole-and-risperidone-for-the-treatment-of-people-with-first-episode-psychosis-123745https://curecurrent.com/trials/mental-healthcare-in-older-adults-with-schizophrenia-123746https://curecurrent.com/trials/clinical-study-of-schizophrenia-in-both-men-and-women-123747https://curecurrent.com/trials/effectiveness-of-a-physical-activity-and-diet-program-in-patients-with-psychotic-disorder-capicor-123748https://curecurrent.com/trials/emotion-endophenotypes-in-schizophrenia-123749https://curecurrent.com/trials/effect-of-varenicline-on-cognitive-function-in-cigarette-smokers-with-schizophrenia-123750https://curecurrent.com/trials/visual-exploration-and-attention-studies-in-patients-with-schizophrenia-and-autism-spectrum-disorders-123751https://curecurrent.com/trials/enhancing-social-interaction-with-an-alterego-artificial-agent-123752https://curecurrent.com/trials/an-outpatient-study-of-the-efficacy-safety-and-tolerability-of-pf-02545920-in-the-adjunctive-treatment-of-sub-optimally-123753https://curecurrent.com/trials/non-invasive-brain-stimulation-for-auditory-verbal-hallucinations-in-schizophrenia-123754https://curecurrent.com/trials/response-shift-and-quality-of-life-in-patients-suffering-from-schizophrenia-and-their-caregivers-123755https://curecurrent.com/trials/sodium-butyrate-for-improving-cognitive-function-in-schizophrenia-123756https://curecurrent.com/trials/feasibility-trial-of-cbt-for-depersonalisation-in-psychosis-123757https://curecurrent.com/trials/motivational-interviewing-to-improve-work-outcomes-in-schizophrenia-123758https://curecurrent.com/trials/a-placebo-controlled-study-of-physiologic-effects-of-l-methylfolate-in-schizophrenia-patients-123759https://curecurrent.com/trials/evaluation-of-mirtazapine-and-folic-acid-for-schizophrenia-123760https://curecurrent.com/trials/self-directed-positive-parenting-program-triple-p-for-psychosis-a-clinical-case-series-123761https://curecurrent.com/trials/trial-and-follow-up-of-the-efficacy-of-two-stage-integrated-treatment-for-chinese-schizophrenia-inpatients-123762https://curecurrent.com/trials/comparison-of-the-effectiveness-of-brexpiprazole-with-that-of-risperidone-123763https://curecurrent.com/trials/acute-psychological-effects-of-high-intensity-exercise-with-schizophrenia-123764https://curecurrent.com/trials/prevalence-of-and-factors-associated-with-metabolic-syndrome-in-schizophrenia-123765https://curecurrent.com/trials/reliability-and-validity-of-thai-calgary-depression-scale-of-schizophrenia-cdss-123766https://curecurrent.com/trials/irish-omega-3-study-123767https://curecurrent.com/trials/the-topical-niacin-skin-flush-test-in-first-episode-psychosis-123768https://curecurrent.com/trials/ontrack-an-online-role-playing-game-a-small-business-innovation-research-sbir-grant-123769https://curecurrent.com/trials/lurasidone-low-dose-high-dose-study-study-123770https://curecurrent.com/trials/non-invasive-brain-stimulation-for-medication-resistant-auditory-hallucinations-in-schizophrenia-patients-123771https://curecurrent.com/trials/fmri-of-theory-of-mind-in-schizophrenia-and-bipolar-disorder-123772https://curecurrent.com/trials/a-study-of-aripiprazole-lauroxil-in-subjects-with-schizophrenia-or-schizoaffective-disorder-123773https://curecurrent.com/trials/safety-tolerability-and-pharmacokinetics-of-apn1125-in-subjects-with-schizophrenia-123774https://curecurrent.com/trials/a-randomized-double-blind-trial-with-6-antipsychotic-drugs-for-schizophrenia-123775https://curecurrent.com/trials/artemisinin-with-risperidone-for-first-episode-and-drug-naive-schizophrenia-123776https://curecurrent.com/trials/a-double-blind-and-randomized-trial-of-celecoxib-added-to-risperidone-in-treatment-naive-first-episode-schizophrenia-123777https://curecurrent.com/trials/ginkgo-biloba-extract-for-schizophrenia-123778https://curecurrent.com/trials/melatonin-treatment-for-tardive-dyskinesia-in-schizophrenia-123779https://curecurrent.com/trials/memantine-add-on-for-cognitive-and-negative-symptoms-of-schizophrenia-123780https://curecurrent.com/trials/minocycline-for-schizophrenia-123781https://curecurrent.com/trials/physical-co-morbidity-poor-health-behaviour-and-health-promotion-in-verona-patients-with-functional-psychoses-123782https://curecurrent.com/trials/emotions-in-schizophrenia-and-bipolar-disorders-a-common-vulnerability-123783https://curecurrent.com/trials/the-use-of-skills-training-to-augment-compensated-work-therapy-cwt-vi-for-veterans-with-smi-123784https://curecurrent.com/trials/group-intervention-for-improving-stigma-coping-and-empowerment-of-people-with-mental-illness-stem-123785https://curecurrent.com/trials/tolerability-and-pharmacokinetics-of-iloperidone-in-adolescent-patients-123786https://curecurrent.com/trials/the-efficacy-of-rehacop-program-in-schizophrenia-123787https://curecurrent.com/trials/understanding-and-helping-families-parents-with-psychosis-123788https://curecurrent.com/trials/adverse-events-and-genomics-in-schizophrenia-123789https://curecurrent.com/trials/the-bc-psychosis-program-biobank-and-database-for-genetic-polymorphisms-and-their-associations-with-psychosis-disorder-123790https://curecurrent.com/trials/pan-european-collaboration-on-antipsychotic-naive-schizophrenia-pecans-123791https://curecurrent.com/trials/cognitive-rehabilitation-in-schizophrenia-123792https://curecurrent.com/trials/the-music-study-in-refractory-psychosis-123793https://curecurrent.com/trials/a-study-to-assess-the-rate-of-hospitalization-in-participants-with-schizophrenia-treated-with-antipsychotics-123794https://curecurrent.com/trials/efficacy-and-safety-of-ave1625-as-a-co-treatment-with-antipsychotic-therapy-in-schizophrenia-123795https://curecurrent.com/trials/randomized-clinical-trial-of-intensive-computer-based-cognitive-remediation-in-recent-onset-schizophrenia-123796https://curecurrent.com/trials/treating-acutely-agitated-patients-with-asenapine-sublingual-tablets-123797https://curecurrent.com/trials/genes-intermediate-phenotypes-and-response-to-quetiapine-rx-123798https://curecurrent.com/trials/glutamate-learning-and-working-memory-123799https://curecurrent.com/trials/single-ascending-dose-study-of-rbp-7000-123800https://curecurrent.com/trials/a-study-of-paliperidone-palmitate-3-month-formulation-for-the-treatment-of-patients-with-schizophrenia-123801https://curecurrent.com/trials/first-in-man-study-of-safety-tolerability-and-pk-profile-of-rbp-7000-123802https://curecurrent.com/trials/a-26-week-extension-study-of-evp-6124-alpha-7-nachr-as-an-adjunctive-pro-cognitive-treatment-in-schizophrenia-subjects-o-123803https://curecurrent.com/trials/study-of-evp-6124-alpha-7-nachr-as-an-adjunctive-pro-cognitive-treatment-in-schizophrenia-subjects-on-chronic-stable-aty-123804https://curecurrent.com/trials/study-of-evp-6124-alpha-7-nachr-as-an-adjunctive-pro-cognitive-treatment-in-schizophrenia-subjects-on-chronic-stable-aty-123805https://curecurrent.com/trials/study-of-paliperidone-palmitate-3-month-and-1-month-formulations-for-the-treatment-of-patients-with-schizophrenia-123806https://curecurrent.com/trials/adjunctive-low-dose-metformin-in-patients-with-schizophrenia-and-metabolic-abnormalities-123807https://curecurrent.com/trials/remediation-of-working-memory-in-schizophrenia-123808https://curecurrent.com/trials/efficacy-of-metacognitive-training-single-modules-jumping-to-conclusions-and-to-empathize-123809https://curecurrent.com/trials/improving-basic-and-social-cognition-in-veterans-with-schizophrenia-123810https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-efficacy-of-clozapine-in-patients-with-treatment-resistant-schizophrenia-123811https://curecurrent.com/trials/brain-connectivity-in-neurodevelopmental-disorders-in-response-to-treatment-123812https://curecurrent.com/trials/acceptance-and-commitment-therapy-for-the-inpatient-treatment-of-psychosis-123813https://curecurrent.com/trials/a-study-to-evaluate-the-effect-of-oral-paliperidone-extended-release-and-oral-risperidone-immediate-release-on-cognitive-123814https://curecurrent.com/trials/safety-tolerability-and-pharmacokinetics-of-single-doses-of-apn1125-in-healthy-normal-subjects-123815https://curecurrent.com/trials/a-study-to-test-the-effectiveness-and-safety-of-a-new-medication-in-the-treatment-of-schizophrenia-123816https://curecurrent.com/trials/lurasidone-pediatric-pharmacokinetics-study-123817https://curecurrent.com/trials/pearl-schizophrenia-maintenance-123818https://curecurrent.com/trials/integrated-coping-and-awareness-training-123819https://curecurrent.com/trials/daaoi-1-treatment-for-treatment-resistant-schizophrenia-123820https://curecurrent.com/trials/monotherapy-brexpiprazole-opc-34712-trial-in-the-treatment-of-adults-with-early-episode-schizophrenia-123821https://curecurrent.com/trials/comparative-bioavailability-study-of-aripiprazole-10-mg-oral-soluble-film-vs-abilify-10-mg-tablet-in-healthy-volunteers-123822https://curecurrent.com/trials/can-we-forget-directed-forgetting-and-embodied-cognition-in-schizophrenia-123823https://curecurrent.com/trials/study-of-the-safety-tolerability-and-pharmacokinetics-of-once-weekly-zicronapine-in-patients-with-schizophrenia-123824https://curecurrent.com/trials/psychoeducation-for-vietnamese-families-with-a-patient-with-schizophrenia-123825https://curecurrent.com/trials/lurasidone-hcl-a-6-week-phase-3-study-of-patients-with-acute-schizophrenia-123826https://curecurrent.com/trials/antipsychotic-augmentation-with-l-dopa-123827https://curecurrent.com/trials/a-safety-and-effectiveness-study-of-paliperidone-palmitate-in-chinese-patients-with-schizophrenia-123828https://curecurrent.com/trials/paliperidone-palmitate-effectiveness-assessment-registry-longitudinal-pearl-123829https://curecurrent.com/trials/olanzapine-vs-low-dose-olanzapine-plus-trifluoperazine-123830https://curecurrent.com/trials/the-effect-of-nitric-oxide-on-spatial-working-memory-in-patients-with-schizophrenia-pilot-study-123831https://curecurrent.com/trials/supported-employment-motivational-enhancement-for-entry-and-outcome-123832https://curecurrent.com/trials/repetitive-transcranial-magnetic-stimulation-rtms-as-an-add-on-treatment-for-resistant-obsessive-compulsive-symptoms-in-123833https://curecurrent.com/trials/multiple-ascending-dose-study-on-safety-tolerability-and-pharmacokinetics-of-amg-581-in-healthy-subjects-or-subjects-wit-123834https://curecurrent.com/trials/mental-health-engagement-network-mhen-123835https://curecurrent.com/trials/efficacy-of-pimozide-augmentation-for-clozapine-partial-response-123836https://curecurrent.com/trials/efficacy-study-of-ga-a-program-cognitive-remediation-of-facial-affects-processing-in-schizophrenia-123837https://curecurrent.com/trials/a-randomized-double-blind-comparison-of-the-efficacy-and-safety-of-amisulpride-versus-low-dose-amisulpride-plus-low-dose-123838https://curecurrent.com/trials/the-family-cognitive-adaptation-training-manual-a-test-of-effectiveness-123839https://curecurrent.com/trials/the-significance-of-deviation-in-time-from-the-12-hour-standard-serum-clozapine-monitoring-123840https://curecurrent.com/trials/oxytocin-as-adjunctive-therapy-for-schizophrenia-123841https://curecurrent.com/trials/effects-of-cognitive-remediation-therapy-on-schizophrenia-patients-through-functional-magnetic-resonance-imaging-123842https://curecurrent.com/trials/transcranial-current-stimulation-as-a-treatment-for-auditory-hallucinations-in-schizophrenia-123843https://curecurrent.com/trials/effectiveness-of-adherence-therapy-for-schizophrenia-123844https://curecurrent.com/trials/guideline-vs-usual-treatment-in-schizophrenic-adolescents-123845https://curecurrent.com/trials/role-of-nintendo-wii-in-improving-negative-symptoms-and-quality-of-life-in-chronic-schizophrenia-123846https://curecurrent.com/trials/org-24448-ampakine-for-cognitive-deficits-in-schizophrenia-123847https://curecurrent.com/trials/impact-a-study-to-explore-the-efficacy-and-safety-of-paliperidone-er-in-patients-with-acute-agitation-123848https://curecurrent.com/trials/remote-monitoring-and-support-for-patients-with-schizophrenia-schizoaffective-or-bipolar-disorder-on-adherence-123849https://curecurrent.com/trials/the-effect-of-plasma-osmolality-on-brain-glutamate-123850https://curecurrent.com/trials/evaluation-of-a-cognitive-adaptive-e-treatment-in-schizophrenia-diagnosed-adults-123851https://curecurrent.com/trials/sodium-oxybate-in-schizophrenia-with-insomnia-123852https://curecurrent.com/trials/safety-and-tolerability-of-aripiprazole-in-adolescents-with-schizophrenia-or-children-and-adolescents-with-bipolar-i-dis-123853https://curecurrent.com/trials/parallel-effects-of-schizophrenia-and-n-methyl-d-aspartate-nmda-antagonism-123854https://curecurrent.com/trials/nicotinic-receptors-and-schizophrenia-123855https://curecurrent.com/trials/nrx-1074-in-early-course-schizophrenia-123856https://curecurrent.com/trials/pet-trial-to-assess-the-receptor-occupancy-of-brexpiprazole-in-adult-subjects-with-schizophrenia-123857https://curecurrent.com/trials/clinical-trial-of-integrated-treatment-versus-standard-treatment-in-first-episode-psychosis-123858https://curecurrent.com/trials/intermittent-theta-burst-stimulation-itbs-for-the-treatment-of-negative-symptoms-in-schizophrenia-123859https://curecurrent.com/trials/e-learning-development-of-an-evidence-based-psychoeducational-programme-for-first-episode-psychosis-123860https://curecurrent.com/trials/a-study-of-paliperidone-palmitate-in-patients-with-schizophrenia-previously-unsuccessfully-treated-by-oral-antipsychotic-123861https://curecurrent.com/trials/prevention-of-n-methyl-d-aspartate-nmda-antagonist-induced-psychosis-in-kids-123862https://curecurrent.com/trials/cbt-for-psychosis-and-affect-on-psychosis-symptoms-123863https://curecurrent.com/trials/treatment-development-targeting-severe-and-persistent-negative-symptoms-123864https://curecurrent.com/trials/social-cognitive-training-for-psychosis-treatment-development-123865https://curecurrent.com/trials/implementation-of-illness-management-and-recovery-in-mental-health-services-123866https://curecurrent.com/trials/spect-investigation-of-the-nmda-receptor-system-in-healthy-volunteers-and-patients-with-schizophrenia-123867https://curecurrent.com/trials/the-influence-of-vitamin-d-on-atypical-antipsychotic-induced-weight-gain-123868https://curecurrent.com/trials/the-role-of-mir-30-family-dysregulation-in-response-to-antipsychotic-treatment-123869https://curecurrent.com/trials/motivational-intervention-for-physical-activity-in-psychosis-123870https://curecurrent.com/trials/genetic-research-in-schizophrenia-using-dna-markers-and-clinical-phenotypes-123871https://curecurrent.com/trials/strengths-based-family-psychoeducation-for-youth-psychosis-123872https://curecurrent.com/trials/shared-decision-making-for-patients-with-first-admission-schizophrenia-123873https://curecurrent.com/trials/brexpiprazole-opc-34712-trial-in-the-treatment-of-adults-with-acute-schizophrenia-123874https://curecurrent.com/trials/efficacy-of-pregnenolone-in-patients-with-schizophrenia-123875https://curecurrent.com/trials/culturally-based-family-therapy-for-improving-treatment-outcome-for-people-with-schizophrenia-123876https://curecurrent.com/trials/efficacy-safety-of-sch-900435-in-schizophrenia-study-p06079-withdrawn-123877https://curecurrent.com/trials/description-of-the-use-of-quetiapine-extended-release-xr-in-real-life-practice-in-france-an-observational-study-123878https://curecurrent.com/trials/serial-comparisons-of-abdominal-and-neurological-mri-scans-123879https://curecurrent.com/trials/effect-of-memantine-on-erp-in-early-schizophrenia-and-healthy-subjects-123880https://curecurrent.com/trials/clozapine-versus-amisulpride-in-treatment-resistant-schizophrenia-patients-123881https://curecurrent.com/trials/switching-from-consta-to-sustenna-in-patients-with-schizophrenia-123882https://curecurrent.com/trials/resveratrol-cardiovascular-risk-markers-and-cognitive-performance-in-patients-with-schizophrenia-123883https://curecurrent.com/trials/the-effect-of-paliperidone-palmitate-in-schizophrenia-123884https://curecurrent.com/trials/is-health-coaching-effective-for-improving-metabolic-health-in-people-with-psychosis-disorders-123885https://curecurrent.com/trials/a-pilot-trial-of-acute-n-acetylcysteine-effects-on-working-memory-and-other-cognitive-functions-in-schizophrenia-123886https://curecurrent.com/trials/efficacy-study-of-opc-34712-in-adults-with-acute-schizophrenia-123887https://curecurrent.com/trials/a-pharmacokinetic-study-of-paliperidone-er-123888https://curecurrent.com/trials/a-study-of-taurine-in-patients-with-first-episode-psychosis-receiving-antipsychotic-treatment-123889https://curecurrent.com/trials/non-interventional-study-of-participants-with-newly-diagnosed-schizophrenia-treated-with-paliperidone-palmitate-123890https://curecurrent.com/trials/integrating-psychotropic-medication-into-the-care-of-people-with-mental-disorders-in-a-prayer-camp-in-ghana-123891https://curecurrent.com/trials/treatment-of-cognitive-impairment-in-men-with-schizophrenia-mk5757-005-completed-123892https://curecurrent.com/trials/parallel-group-multiple-dose-pharmacokinetics-study-of-five-antipsychotic-medications-in-psychiatric-participants-123893https://curecurrent.com/trials/trial-to-evaluate-the-effects-of-opc-34712-on-qt-qtc-in-subjects-with-schizophrenia-or-schizoaffective-disorder-123894https://curecurrent.com/trials/multicenter-open-label-safety-and-tolerability-study-123895https://curecurrent.com/trials/trial-evaluating-opc-34712-in-subjects-with-normal-renal-function-and-renally-impaired-subjects-123896https://curecurrent.com/trials/study-of-the-effectiveness-of-three-different-doses-of-opc-34712-in-the-treatment-of-adults-with-acute-schizophrenia-123897https://curecurrent.com/trials/the-neural-bases-of-early-visual-and-auditory-processing-and-emotion-recognition-deficits-in-schizophrenia-123898https://curecurrent.com/trials/acute-glycine-pharmacodynamic-study-123899https://curecurrent.com/trials/single-ascending-dose-study-with-a-food-effect-cohort-to-evaluate-amg-581-123900https://curecurrent.com/trials/a-study-to-test-the-safety-and-efficacy-of-mk-8998-in-acutely-psychotic-participants-with-schizophrenia-mk-8998-004-123901https://curecurrent.com/trials/study-to-evaluate-the-efficacy-safety-and-tolerability-of-oral-opc-34712-and-aripiprazole-for-treatment-of-acute-schizop-123902https://curecurrent.com/trials/a-study-evaluating-the-of-opc-34712-in-subjects-with-normal-hepatic-function-and-hepatically-impaired-subjects-123903https://curecurrent.com/trials/cognitive-behaviour-therapy-and-cognitive-training-in-work-rehabilitation-for-persons-with-severe-mental-illness-123904https://curecurrent.com/trials/electroconvulsive-therapy-in-clozapine-resistant-schizophrenia-123905https://curecurrent.com/trials/clinical-validation-of-the-rating-scale-for-psychotic-depression-ras-pd-123906https://curecurrent.com/trials/targeted-vitamin-d-treatment-of-schizophrenia-associated-hyperprolinemia-123907https://curecurrent.com/trials/contingent-incentives-plus-bupropion-for-smoking-in-people-with-schizophrenia-123908https://curecurrent.com/trials/intervention-module-ages-123909https://curecurrent.com/trials/improving-adherence-to-oral-antipsychotic-medications-in-people-with-schizophrenia-123910https://curecurrent.com/trials/acute-effects-of-exercise-in-smokers-with-schizophrenia-123911https://curecurrent.com/trials/rct-of-methotrexate-added-to-treatment-as-usual-in-schizophrenia-123912https://curecurrent.com/trials/the-two-way-communication-checklist-2-com-in-first-episode-psychosis-patients-in-hong-kong-123913https://curecurrent.com/trials/a-follow-on-study-of-the-long-term-safety-of-aripiprazole-in-patients-with-chronic-schizophrenia-123914https://curecurrent.com/trials/the-effects-of-cannabis-use-in-people-with-schizophrenia-on-clinical-neuropsychological-and-physiological-phenotypes-123915https://curecurrent.com/trials/the-influence-of-omega-3-fatty-acid-on-the-violence-of-schizophrenia-patient-and-the-possible-mechanism-123916https://curecurrent.com/trials/influence-of-emotion-in-a-test-run-forgetfulness-123917https://curecurrent.com/trials/neurocognitive-effects-of-ziprasidone-relationship-to-working-memory-and-dopamine-blockade-123918https://curecurrent.com/trials/effects-of-rtms-on-cigarette-smoking-and-cognition-in-schizophrenia-123919https://curecurrent.com/trials/specific-cognitive-remediation-for-schizophrenia-123920https://curecurrent.com/trials/efficacy-of-an-occupational-time-use-intervention-for-people-with-serious-mental-illness-123921https://curecurrent.com/trials/auditory-brainstem-response-as-a-diagnostic-tool-in-schizophrenia-and-bipolar-disorder-123922https://curecurrent.com/trials/repetitive-transcranial-magnetic-stimulation-and-intermittent-theta-burst-itbs-in-schizophrenia-123923https://curecurrent.com/trials/effects-of-transcranial-direct-current-stimulation-in-individuals-with-schizophrenia-123924https://curecurrent.com/trials/culturally-adapted-family-intervention-for-psychosis-123925https://curecurrent.com/trials/effects-of-varenicline-on-plasticity-in-schizophrenia-123926https://curecurrent.com/trials/pilot-study-of-pregnenolone-augmentation-targeting-cognitive-symptoms-in-persistently-symptomatic-patients-with-schizoph-123927https://curecurrent.com/trials/anticholinergic-burden-in-schizophrenia-123928https://curecurrent.com/trials/a-study-of-usage-of-paliperidone-palmitate-in-patients-with-schizophrenia-in-a-hospital-setting-123929https://curecurrent.com/trials/mk0557-for-the-treatment-of-cognitive-impairment-in-patients-with-schizophrenia-0557-027-123930https://curecurrent.com/trials/psychiatric-disorders-and-electrophysiological-markers-123931https://curecurrent.com/trials/smoking-cessation-for-veterans-with-severe-and-persistent-mental-illness-123932https://curecurrent.com/trials/interest-of-repetitive-transcranial-magnetic-stimulation-rtms-in-the-treatment-of-auditory-hallucinations-123933https://curecurrent.com/trials/cognitive-behavioral-therapy-for-post-traumatic-stress-disorder-in-individuals-with-severe-mental-illness-123934https://curecurrent.com/trials/cognitive-remediation-in-22q11ds-123935https://curecurrent.com/trials/niapsan-as-add-on-therapy-to-antipsychotic-treatment-in-first-episode-psychosis-123936https://curecurrent.com/trials/mk0249-for-the-treatment-of-cognitive-impairment-in-patients-with-schizophrenia-0249-016-123937https://curecurrent.com/trials/deep-brain-stimulation-dbs-for-the-management-of-treatment-refractory-negative-symptoms-in-schizophrenia-123938https://curecurrent.com/trials/an-open-study-of-sulforaphane-rich-broccoli-sprout-extract-in-patients-with-schizophrenia-123939https://curecurrent.com/trials/20101299-study-to-evaluate-the-effect-of-amg-747-on-schizophrenia-negative-symptoms-123940https://curecurrent.com/trials/randomized-controlled-double-blind-trial-of-eszopiclone-for-insomnia-associated-with-schizophrenia-123941https://curecurrent.com/trials/assessing-the-effects-of-fanapt-on-social-cognition-in-schizophrenia-123942https://curecurrent.com/trials/safety-and-tolerability-study-of-aripiprazole-im-depot-in-adult-subjects-with-schizophrenia-123943https://curecurrent.com/trials/investigation-of-the-drug-dimethoxbenzylidene-anabaseine-in-treating-schizophrenia-patients-123944https://curecurrent.com/trials/contingency-management-for-smoking-cessation-among-veterans-with-psychotic-disorders-123945https://curecurrent.com/trials/study-of-the-effect-of-single-doses-of-mk2637-and-dextromethorphan-on-cerebral-cortex-excitability-2637-008-123946https://curecurrent.com/trials/influence-of-acupuncture-on-emotional-measures-and-quality-of-sleep-among-schizophrenia-patients-123947https://curecurrent.com/trials/lurasidone-hcl-a-long-term-safety-phase-3-study-of-patients-with-clinically-stable-schizophrenia-123948https://curecurrent.com/trials/clinical-effectiveness-of-newer-antipsychotics-in-comparison-with-conventional-antipsychotics-in-schizophrenia-123949https://curecurrent.com/trials/an-randomized-open-label-pk-study-of-ly03004-compared-to-risperdal-consta-in-stable-patients-with-schizophrenia-or-schiz-123950https://curecurrent.com/trials/catie-schizophrenia-trial-123951https://curecurrent.com/trials/cognitive-adaptive-training-for-improving-medication-adherence-symptoms-and-function-in-people-with-schizophrenia-123952https://curecurrent.com/trials/lurasidone-hcl-a-phase-3-study-of-patients-with-acute-schizophrenia-123953https://curecurrent.com/trials/lurasidone-hcl-a-long-term-phase-3-study-of-patients-with-chronic-schizophrenia-123954https://curecurrent.com/trials/a-study-of-subjects-switched-to-lurasidone-for-the-treatment-of-schizophrenia-or-schizoaffective-disorder-123955https://curecurrent.com/trials/oxytocin-treatment-of-social-cognitive-and-functional-deficits-in-schizophrenia-123956https://curecurrent.com/trials/treatment-study-comparing-aripiprazole-once-monthly-with-standard-of-care-medication-in-outpatients-with-schizophrenia-123957https://curecurrent.com/trials/treating-schizophrenic-smokers-effects-on-craving-cues-and-withdrawal-123958https://curecurrent.com/trials/n-acetylcysteine-nac-for-improving-cognitive-dysfunction-in-schizophrenia-123959https://curecurrent.com/trials/cognitive-behavioral-social-skills-training-for-improving-social-functioning-in-people-with-schizophrenia-123960https://curecurrent.com/trials/efficacy-safety-and-tolerability-of-tc-5619-as-augmentation-therapy-to-improve-negative-symptoms-and-cognition-in-outpat-123961https://curecurrent.com/trials/niacin-skin-flush-response-in-patients-with-schizophrenia-123962https://curecurrent.com/trials/a-study-of-ro4917838-in-patients-with-sub-optimally-controlled-symptoms-of-schizophrenia-nn25307-123963https://curecurrent.com/trials/functional-rehabilitation-for-older-patients-with-schizophrenia-123964https://curecurrent.com/trials/phosphodiesterase-pde-inhibitors-effect-on-cognitive-deficits-associated-to-schizophrenia-123965https://curecurrent.com/trials/factors-association-with-poor-physical-function-in-older-adults-with-schizophrenia-123966https://curecurrent.com/trials/long-term-safety-extension-trial-of-asenapine-in-schizophrenia-participants-who-completed-protocol-p05688-p05689-123967https://curecurrent.com/trials/enhancing-synaptic-plasticity-and-cognition-in-schizophrenia-123968https://curecurrent.com/trials/risperidone-controlled-multicentre-clinical-trial-of-iloperidone-in-patients-with-schizophrenia-123969https://curecurrent.com/trials/extended-duration-nicotine-replacement-therapy-and-bupropion-in-smokers-with-schizophrenia-123970https://curecurrent.com/trials/a-brief-community-linkage-intervention-for-dually-diagnosed-individuals-123971https://curecurrent.com/trials/fmri-cholinergic-mechanisms-in-schizophrenia-123972https://curecurrent.com/trials/a-definitive-estrogen-patch-study-adept-123973https://curecurrent.com/trials/rosiglitazone-for-clozapine-induced-glucose-metabolism-impairment-123974https://curecurrent.com/trials/usability-of-a-website-for-people-with-schizophrenia-123975https://curecurrent.com/trials/open-label-study-to-compare-hospitalization-rates-of-schizophrenic-patients-treated-with-oral-antipsychotics-versus-im-d-123976https://curecurrent.com/trials/peony-glycyrrhiza-decoction-pgd-for-antipsychotic-induced-hyperprolactinemia-in-patients-with-schizophrenia-123977https://curecurrent.com/trials/study-of-talnetant-versus-placebo-and-risperidone-in-schizophrenia-123978https://curecurrent.com/trials/morphological-structural-and-functional-neural-substrates-of-quality-of-life-in-schizophrenia-123979https://curecurrent.com/trials/adherence-to-treatment-safety-and-tolerability-study-of-the-medical-information-device-1-mind1-in-subjects-with-schizoph-123980https://curecurrent.com/trials/pilot-study-using-an-nmda-antagonist-to-modulate-transcranial-direct-current-stimulation-tdcs-effects-on-sensory-discrim-123981https://curecurrent.com/trials/a-patient-centered-approach-to-improve-screening-for-side-effects-of-second-generation-antipsychotics-sgas-123982https://curecurrent.com/trials/patient-centered-medication-adherence-intervention-for-schizophrenia-123983https://curecurrent.com/trials/15-month-study-for-adults-who-have-been-diagnosed-with-schizophrenia-and-incarcerated-123984https://curecurrent.com/trials/relation-of-catechol-o-methyltransferase-comt-genotype-and-response-to-cognitive-remediation-schizophrenia-123985https://curecurrent.com/trials/high-dose-of-quetiapine-in-treating-subjects-with-treatment-refractory-schizophrenia-or-schizoaffective-disorder-123986https://curecurrent.com/trials/csp-572-genetics-of-functional-disability-in-schizophrenia-and-bipolar-illness-123987https://curecurrent.com/trials/effectiveness-of-an-interactive-educational-website-for-improving-the-quality-of-mental-health-care-for-people-with-schi-123988https://curecurrent.com/trials/equivalence-of-generic-clozapine-to-orally-dissolving-clozapine-in-schizophrenia-or-schizoaffective-disorder-123989https://curecurrent.com/trials/aggressive-treatment-of-metabolic-syndrome-in-patients-receiving-clozapine-for-schizophrenia-123990https://curecurrent.com/trials/neurocognitive-training-integrated-in-opus-treatment-versus-opus-treatment-as-usual-123991https://curecurrent.com/trials/adherence-in-patients-admitted-to-a-psychiatric-unit-for-acute-psychosis-an-analysis-of-serum-levels-of-antipsychotics-123992https://curecurrent.com/trials/effects-of-eltoprazine-on-cognitive-impairment-associated-with-schizophrenia-cias-in-adults-123993https://curecurrent.com/trials/famotidine-in-schizophrenia-123994https://curecurrent.com/trials/mindfulness-meditation-as-a-rehabilitation-strategy-for-persons-with-schizophrenia-123995https://curecurrent.com/trials/effectiveness-of-pimozide-in-augmenting-the-effects-of-clozapine-in-the-treatment-of-schizophrenia-123996https://curecurrent.com/trials/psychiatric-advance-directives-for-improved-mental-health-care-123997https://curecurrent.com/trials/a-multi-site-study-of-strategies-for-implementing-schizophrenia-guidelines-123998https://curecurrent.com/trials/improving-antipsychotic-adherence-among-patients-with-serious-mental-illness-123999https://curecurrent.com/trials/improving-health-services-for-veterans-with-schizophrenia-124000https://curecurrent.com/trials/clozapine-versus-haloperidol-for-treating-the-first-episode-of-schizophrenia-124001https://curecurrent.com/trials/clozapine-versus-chlorpromazine-for-treatment-unresponsive-schizophrenia-124002https://curecurrent.com/trials/evaluating-a-collaborative-care-model-for-the-treatment-of-schizophrenia-equip-124003https://curecurrent.com/trials/a-study-of-strategies-to-improve-schizophrenia-treatment-124004https://curecurrent.com/trials/effectiveness-of-clozapine-versus-olanzapine-for-treatment-resistant-schizophrenia-124005https://curecurrent.com/trials/functional-rehabilitation-of-older-patients-with-schizophrenia-124006